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ABSTRACT 
 
Monica High 
A murine model of genetic determinants of RSV disease 
(Under the direction of Steven Kleeberger) 
 
Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory tract 
infection (LRTI) in infants.  Approximately 70% of infants are infected with RSV within 
the first year of life.  Epidemiological studies show that individuals have varying severity 
of RSV disease, ranging from “cold-like” symptoms to death.  Previous in vivo studies 
have suggested that RSV susceptibility is a polygenic trait; however, the specific genes 
regulating RSV disease have yet to be identified.  The objective of this dissertation was to 
identify candidate genes that regulate differences in RSV disease severity between inbred 
mouse strains. 
Thirty-six inbred mouse strains were infected with a single dose of 1x106 plaque 
forming units of RSV or control and sacrificed 1 and 5 days post-infection (pi).  
Inflammatory response, lung permeability, pathology, mucus cell metaplasia, and viral 
load were analyzed and compared among and within all inbred strains.  Using in silico 
haplotype association mapping, the degree of correlation between the observed 
phenotypic differences and the genotype of the inbred strains was used to determine 
candidate QTLs.  
RSV disease phenotypes were distributed continuously across inbred strains.  
Furthermore, the strain distribution patterns varied for each phenotype and time point, 
suggesting that multiple mechanisms influence RSV susceptibility.  Correlation analysis 
of phenotype relatedness also suggests that the response to RSV at 1 and 5 days pi are 
independent.  
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Gene expression was minimally altered by RSV infection in “non-responsive” 
strains (e.g. C3H/HeJ); however, gene expression did vary significantly as a result of 
RSV infection in responsive inbred strains (e.g. BALB/cByJ).  In responsive strains the 
most significant change in gene expression was noted 1 day following infection when a 
significant number of genes were either up-regulated or down-regulated.  It was 
determined that genes involved in antigen presentation, infection mechanisms, and 
inflammatory response pathways were differentially activated between responsive and 
non-responsive strains.  Based on the expression profile and biological plausibility a few 
of these genes (e.g. Marco, Tlr4, Stat4, Mx1, Ccl12, Cx3cr1) were identified as candidate 
genes for response to RSV infection. In vivo proof-of-principle investigations confirmed 
the role of Cx3cr1 and Marco as candidate genes for RSV susceptibility and disease.   
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To my parents who always believed in me. 
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INTRODUCTION
 2
Oxidative Stress and Lung Disease 
Oxidative stress results from an oxidant/ antioxidant imbalance in favor of 
oxidants, which results in a process generating reactive oxygen species (ROS).  ROS are 
highly reactive molecules with unpaired electrons, capable of causing oxidation (1).  
Common ROS include superoxide anion, hydrogen peroxide, and hydroxyl radicals.  
Biological systems are constantly challenged by endogenous ROS or ROS formed from a 
metabolic process (2).  Due to their reactive nature ROS may cause damage to lipids, 
proteins, and DNA, in addition to inducing numerous cellular responses (3).  Since the 
lung epithelium is exposed directly to the environment it is exposed to high levels of 
oxygen, oxidant gases, and particulate matter, it is especially vulnerable to ROS mediated 
injury.  There is accumulating evidence that oxidative stress and ROS plays a role in the 
pathogenesis of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis 
(CF), pulmonary fibrosis, lung cancer, acute lung injury (ALI) (4-6). 
 
Oxidative Stress and Asthma 
 Asthma is a chronic inflammatory disease of the airways that is characterized by 
airway eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness (AHR) in 
response to inhaled allergens (7, 8).  It is widely agreed that inflammation, which is 
characteristic of asthma results in increased oxidative stress and ROS production in the 
airways (9).  Alveolar macrophages, eosinophils, and neutrophils of asthmatics have 
increased O2 release and ROS production compared to healthy individuals (10, 11).  This 
increase leads to increased hydrogen peroxide, 8-isoprostane and CO in breath 
condensates, increased glutathione peroxidase and superoxide dismutase in lung cells, 
and elevated levels of eosinophil peroxidase and myeloperoxidse in the peripheral blood, 
sputum and bronchoalveolar lavage fluid (BALF) in patients (12-14).  These ROS 
contribute to airway smooth muscle contraction, β-adrenergic receptor dysfunction, loss 
of function of epithelial cilia, increased mucus production, an increase of inflammatory 
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cells and amplified vascular permeability (15).  β-adrenergic receptor dysfunction leads 
to an increase in vagal tone and H2O2 production initiates airway smooth muscle 
contraction, both resulting in AHR in animal models (16, 17).  Previous studies indicate 
that ROS also prompt mast cells to release histamine, and cause epithelial cells to secrete 
mucus (18).  Continuous exposure to ROS will cause oxidative damage and epithelial cell 
sloughing (19).  Once this barrier is damaged and unable to function properly the lung is 
vulnerable to permeability to fluid, macromolecules and inflammatory cells. 
 
Oxidative Stress and Acute Lung Injury 
 Acute lung injury (ALI) is a disease characterized by diffuse inflammation of the 
lung parenchyma resulting in a sudden reduction in gas exchange, static compliance and 
non-hydrostatic pulmonary edema (15, 20).  The pathogenesis of ALI is not completely 
understood; however, oxidant-mediated tissue injury is believed to be an important factor 
in the pathogenesis of ALI.  ROS are believed to play an important role in pulmonary 
vascular endothelial damage, which is hypothesized to be responsible for the signs and 
symptoms of ALI.  Patients with ALI have elevated levels of hydrogen peroxide in 
exhaled air and urine.  In addition to enhanced ROS production, diminished antioxidant 
levels are also linked to ALI pathogenesis (21, 22).  For example, decreased levels of 
GSH, vitamins C and E, endogenous scavenger of ROS, have been observed in detected 
in the alveolar fluid of patients with ALI (23).  Exposure to ozone (O3) is a widely 
accepted animal model for ALI.  Under this circumstance ROS are generated as a result 
of neutrophil and macrophage activation (24). 
 In response to inflammatory stimuli, lung endothelial cells, alveolar cells, airway 
epithelial cells and activated macrophages can indirectly mediate production of ROSs 
such as NO and O2- (25).  These compounds form peroxynitrite, which nitrates and 
oxidizes key amino acids in various lung proteins, resulting in modified proteins and 
inhibits their function.  Modified proteins have been detected ex vivo in samples from 
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patients with ALI.  Expression of inflammatory cytokines, chemokines and adhesion 
molecules are elevated during ALI, and may result in ROS formation.  Studies have 
suggested that high concentrations of TNF-α and IL-1β are detected in the BALF of 
patients suffering from ALI (26). 
 
Ozone (O3)-Induced Oxidative Stress and Lung Injury 
 Ozone (O3) is an allotropic form of O2, which is more reactive, less stable and 
decomposes more readily than O2.  O3 in ambient air is attributed to intrusion of 
stratospheric O3 or through a photochemical reaction requiring reactive hydrocarbons, 
sunlight and nitrogen dioxide (NO2).  NO2 is a major component of air pollution, 
produced mainly by motor vehicles.  In the troposphere, NO2 absorbs longer wavelength 
UV light, which leads to the following reactions: 
NO2 + UV photons → O + NO 
O + O2 → O3 
O3 + NO → NO2 + O2 
 Clinical studies found that increases in ambient outdoor O3 levels were associated 
with exacerbation of respiratory disease and excess mortality in some populations (27-
29).  Exposure to O3 causes airway inflammation, airway hyperresponsiveness, and 
overall decreased lung function (30-32).  In controlled human studies O3 inhalation 
increases the airway levels of inflammatory mediators (e.g IL-8, GRO-α, ICAM-1), and 
depletes levels of protective antioxidants (e.g. ascorbic acid, glutathione peroxidase) in 
bronchoalveolar lavage fluid (BALF) (30, 33-35).    
 Even though studies have determined that certain inflammatory mediators 
regulate host response to O3, the exact mechanism by which O3 mediates these effects is 
mostly unknown, but may involve the generation of ROS such as H2O2, NO and hydroxyl 
radicals (18, 36-39).  O3 reacts with lipids in the epithelial lining fluid, producing 
aldehydes and hydroperoxides which initiate a cascade of events leading to the release of 
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chemokines from the epithelium that recruit inflammatory cells into the airways (40-42).  
The responding inflammatory cells release ROS which are believed to contribute to the 
lung injury normally found following O3 exposure (43-45).  Antioxidants such as ascorbic 
acid, are scavengers of O3 and NO2, and protect the lung from the damaging effects of O3 
(46).   
 
Genetic aspect of O3 susceptibility 
While earlier studies suggest that O3 mediates respiratory disease, later research 
found that these effects differ between individuals.  Certain sub-sets of the population 
including the elderly, immunocompromised, and individuals with pre-existing respiratory 
disease are more susceptible to O3 (47, 48).  Besides these factors additional evidence 
suggests that the genetic background of the individual influences the disease response 
(24, 49).  In humans, gene polymorphisms have been associated with susceptibility to 
many environmental agents such as pesticides and particulate matter.  Currently there are 
many ongoing studies aimed at identifying genes believed to be associated with O3 
susceptibility. 
 
Approaches to identifying candidate genes 
 Two approaches can be used to identify genes that regulate susceptibility (50-52).  
The first and most common method is the candidate gene approach, in which genes are 
chosen a priori as likely mechanisms that influence the phenotype of interest.  
Association is assessed between the phenotype of interest and polymorphisms within the 
candidate gene(s).  This approach is effective at identifying genes that regulate the 
phenotype of interest.  However, since it does not examine the entire genome it is unable 
to identify all the genes that affect the phenotype.  Furthermore this approach fails to take 
gene-gene interaction into account (53).  The second approach is a genome scan 
(positional cloning).  Similar to the candidate gene approach this method associates gene 
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expression and polymorphisms with the phenotype of interest.  However, unlike the 
candidate gene approach a genome-wide screen is used to identify linkage to any 
chromosomal interval throughout the entire genome between two or more differentially 
responsive strains.  This approach requires no prior knowledge of gene function and has 
the potential to discover novel disease genes.   
 
CX3CR1 as a candidate gene 
 CX3CR1 is the only member of the CX3C family of chemokines receptors, and is 
the primary receptor for fractalkine (CX3CL1).  Membrane-bound CX3CR1-fractalkine 
interaction regulates adhesion of monocytes, macrophages, natural killer (NK) cells and 
T lymphocytes (54).  Soluble fractalkine exhibits efficient chemotactic activity for 
monocytes, macrophages, NK cells, and T lymphocytes expressing CX3CR1 (54-57).  
This ligand-receptor complex is very diverse, regulating both cell-cell interaction and cell 
migration.  In the years since it was identified (1997), CX3CR1 expression and activation 
has been associated with inflammation, and the progression of many diseases.  The role 
of CX3CR1 in carotid cardiovascular disease is well characterized.  Single nucleotide 
polymorphisms (SNPs) of CX3CR1 are linked to attenuation of cardiovascular disease 
(58-60), and additional studies found that polymorphisms within CX3CR1 are associated 
with resistance to HIV-1 infection (61-63).  In spite of all that is known about the 
function CX3CR1 and its role in disease progression, very little in known about how it 
regulates pulmonary inflammation and injury.  A previous study investigated the role 
CX3CR1 plays in lung injury.  Investigators found that polymorphisms in 
CX3CR1associated with decreased incidence of CWP.  This group concluded that the 
chemokine receptor CX3CR1 plays a role in lung injury resulting from chronic exposure 
to coal dust (64).  However, the role of CX3CR1 in lung injury following subacute 
exposure is still unknown.  While no evidence exists that CX3CR1 promotes pulmonary 
responses to acute oxidant exposures, this gene is expressed in the lung and modulates 
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chronic inflammation (e.g. CWP, emphysema), and therefore might influence the 
initiation or development of inflammatory responses in that organ (64, 65).  Based on 
what is known about CX3CR1 it is a promising candidate gene for susceptibility to O3-
induced inflammation.   
 
Objective of Chapter 2 
 
The overall objective of the studies described in Chapter 2 was to test the 
hypothesis that Cx3cr1 contributes to O3-induced inflammation in the mouse, and to 
investigate the mechanisms through which Cx3cr1 modulates the effect. 
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Virus-induced oxidative stress and lung injury 
 
Respiratory Syncytial Virus 
 RSV is an enveloped ssRNA virus in the Paramyxovirus family.  The viral 
genome of RSV encodes 8 structural and 2 non-structural proteins.  Important structural 
proteins include the fusion (F) protein and the attachment (G) protein (66, 67).  These 
two proteins are essential for viral penetration and attachment to host cells, and both are 
important in the development of immune responses and producing protective antibodies.  
The G protein regulates viral attachment, and the F protein mediates viral penetration and 
syncytium formation (68).   
RSV replication follows specific events.  The virus attaches to the host cell using 
the G protein, and the viral envelope fuses with the plasma membrane through the F 
protein.  Following penetration, the viral nucleocapsid is released into the cellular 
cytoplasm.  The viral RNA is a template for mRNA, which is a template for translation of 
viral proteins and cDNA is a template for transcription of virion RNA.  This is a complex 
process that can only occur inside of the bronchopulmonary tree and viral infection is 
restricted to the respiratory mucosa.   
 
Epidemiology and clinical impact 
Respiratory syncytial virus (RSV) is the primary cause for hospitalization during 
the first year of life, and is the leading cause of bronchiolitis, pneumonia, mechanical 
ventilation and respiratory failure in infants worldwide (69, 70).  RSV infection is also 
associated with the development of childhood asthma, and recurrent wheezing up to 7 
years old (71-73).  In the United States alone, more than 100,000 infants are hospitalized 
with RSV-induced bronchiolitis each year (74).  Hospitalization rates are the highest 
among premature infants, and those with compromised immune systems.  Throughout the 
world approximately 100% of children are infected with RSV by their second birthday, 
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and over half of these children have already experienced reinfection (75).  RSV “season” 
usually correlates with flu season and cases in the United States peak in January or 
February (76).  RSV is highly virulent and only a small percentage of infections are 
completely asymptomatic.  While the majority of infected individuals present symptoms, 
the nature and severity of the symptoms vary among individuals.  For some infants 
infection induces cold-like symptoms, others require hospitalization, and a few cases 
actually result in death.  In most infants RSV causes an upper respiratory tract infect 
(URTI), which is followed by a mild lower respiratory tract infection (LRTI) in about 
40% of cases.  Viral LRTI are particularly serious in infants, because the lungs are still 
adapting to the extrauterine environment (77).  In humans, signs of URTI include 
tachnypea, hyperinflation, crackles and expiratory wheezing (75).  RSV infection usually 
subsides after a week.  In general very few “healthy” suffer from life threatening RSV 
infection, and hospitalization and deaths are confined to infants who have preexisting 
cardiopulmonary disease or those who are immunocompromised (70, 78).  Epidemiology 
studies found that the average age of onset is 13 months; the most severe cases are 
usually found in infants between 8 and 30 weeks old (70, 78, 79).  The highest mortality 
risk for RSV is among infants younger than 6 months (80).  
Children are not the only population at risk to RSV infection; RSV is also a 
significant cause of respiratory illness in immunocompromised adults and the elderly (81, 
82).  Among these populations RSV is responsible for 10.6% of pneumonia cases, 11.4% 
of chronic obstructive pulmonary disease (COPD) hospitalizations, 7.2% of 
hospitalizations related to asthma, and 5.4% of congestive heart failure cases (81, 83).  
The wide spread occurrence of RSV infection has fueled the urgency of research for 
prophylactic therapies.  In the 1960’s Chanock and Parrott developed a vaccine 
containing formalin-inactivated RSV (FI-RSV).  This vaccine was administered to 141 
children in the Washington, DC area.  Nine months after vaccination approximately 60 of 
the 141 children presented symptoms of RSV infection.  Not only did the vaccine fail to 
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protect the children from infection, it also caused these children to experience an 
exacerbated form of the disease and was the cause of at least 4 infant deaths (68, 84, 85).  
The exact reason for enhanced disease is still not known.  Despite the vast amount of 
research aimed at RSV infection, the complexities of the disease and its phenotypes cause 
the specific pathogenic mechanism to remain a mystery.  Without some insight into the 
pathogenesis of primary infection effective vaccines and efficacious post-infection 
therapies are not currently available.  
 
Respiratory Syncytial Virus and the immune response 
Over the years nearly all components of the immune system have been implicated 
in the pathogenesis of RSV infection, including inflammatory cells and their products 
such as chemokines, cytokines, and soluble inflammatory mediators.  Currently there is 
controversy surrounding the role all of these components play in the pathogenesis of RSV 
infection; specifically, whether RSV-specific antibodies produce disease enhancing 
effects (75, 85-89).  Some studies show that infants with high titers of transplacentally 
acquired antibodies are less likely to develop severe bronchiolitis, and pre-treatment with 
RSV-intravenous immunoglobulin and monoclonal antibodies mitigates RSV infection, 
suggesting that RSV-specific antibodies may have a protective role against infection (90, 
91).  However, elevated levels of RSV-specific IgE antibodies were detected in 
individuals with severe RSV infection, compared to those with milder forms of the 
disease.  These elevated levels suggest that the immune response to RSV infection 
predisposes the child to wheezing.  Epidemiology studies found that asthma and allergic 
sensitization were both significantly higher in children previously infected with RSV (71, 
72, 77, 92-94).  However, there is still controversy on whether RSV is the actual cause of 
allergy or if genetic predisposition to allergy increases the child’s susceptibility to RSV 
infection. 
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 As mentioned previously, immunocompromised individuals are at greater risk for 
developing severe complications from RSV infection, suggesting that the cellular 
immune response is essential in terminating the infection.  Several studies show 
depressed levels of CD8+ T cells in the peripheral blood children with RSV bronchiolitis, 
confirming that the defect in the immune system is regulated by CD8+ cells or 
redistribution of CD8+ cells to the lungs (95-98).  In mice, investigators found extensive 
redistribution of CD8+ cells toward the lungs from peripheral blood during RSV 
infection.  Response to RSV infection is widely believed to be mediated by a balance 
between Th1 and Th2 cells (99, 100).  Th1 cells produce interferon gamma (IFNγ) and 
interleukin 2 (IL-2), and are generally observed in infectious disease processes involving 
microorganisms and delayed hypersensitivity.  A Th2 response is associated with 
parasitic infections and allergic diseases such as asthma; these cells secrete IL-4, IL-5, 
IL-10 and IL-13, cytokines that induce specific immunoglobulin production by B cells.  
Recent studies have found associations with all the aforementioned cytokines and their 
receptors to either RSV susceptibility or immune response (88, 93, 101-108).  IL-4 is 
known to have a chemotactic effect on eosinophils, and IL-5 stimulates eosinophil 
proliferation, which leads to eosinophilia in RSV infected individuals.  In mice, distinct 
patterns of cytokine production are observed after RSV challenge following priming with 
either G or F RSV surface proteins.  Mice treated with G-specific cells exhibited a severe 
form of RSV characterized by significant eosinophilia.  Conversely, F-specific cells only 
exhibited only a slight increase on pulmonary inflammation, and eosinophilia was not 
observed.  These finding suggest that RSV bronchiolitis results from Th2 response, and 
Th1 response is responsible for the non-wheezing illnesses associated with RSV.  RSV 
reduces IFNγ production, and IL-4 production is reduced to a lesser degree, resulting in a 
significantly increased IL-4/ IFNγ ratio compared to controls (109).  Because IFNγ levels 
were affected more than IL-4 it is believed that RSV infection favors a Th2 profile.   
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 IFNγ, which is produced by natural killer cells, has antiviral activity and promotes 
cell-mediated immune responses to viruses.  High levels of this cytokine can be found in 
mice in the early stages of viral infection (108).  Elevated IFNγ is detected in BAL from 
BALB/c as early as 1 day post-infection, and peak levels are detected once viral 
clearance is near completion, and lung function abnormalities are at their maximum 
(roughly 6 days after infection) (108).  While RSV induces IFNγ secretion in mice it is 
not a potent inducer in humans.  However, treatment with anti- IFNγ reduced airway 
hyperresponsiveness, but has no effect on eosinophilia (109).  Receptors for IFNγ are 
found on eosinophils and activation of IFNγ is believed to initiate eosinophilia associated 
with RSV infection. 
 
Respiratory Syncytial Virus and Oxidative Stress  
 Previous studies suggest that RSV infection leads to oxidative stress, which 
contributes to alveolar epithelial cell injury (110-112).  As mentioned previously IFNγ is 
believed to contribute the RSV-induced immune response.  As part of the Th1 response 
IFNγ causes lymphocyte migration and nitric oxide (NO) synthase induction, resulting in 
ROS formation and epithelial cell damage (108, 113).   
Previous studies indicate that the transcription factor NF-E2 like 2 (Nrf2) has a 
protective effect against oxidative stress, and ultimately the disease phenotypes (114).  
Nrf2 was originally identified in a screen for proteins that interact with the control region 
of β-globin gene.  Nrf2 is found in almost all tissues in the body, but is present in high 
concentrations in tissues where detoxification occurs regularly, such as the lung (110).  
Cho et al. found that Nrf2-/- mice were at significantly greater risk for RSV disease 
phenotypes, including pulmonary inflammation, oxidative stress, and mucus cell 
metaplasia, compared to Nrf2+/+ mice (110).  Furthermore, antioxidant and other 
protective enzymes normally upregulated by RSV were inhibited in Nrf2-/- mice relative 
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to Nrf2+/+ mice.  These studies were consistent with a role for Nrf2-mediated defense 
against RSV-induced oxidative stress and disease. 
 
Respiratory Syncytial Virus and Genetic Susceptibility    
 As previously mentioned the severity and nature of RSV infection varies between 
individuals.  Effects can range from asymptomatic to death, with the majority of cases 
presenting mild upper respiratory tract infection (URTI) with cold-like symptoms.  Viral 
strain differences play a minor role in this variation (115-119); and studies indicate that 
environmental factors, age and gender may contribute to susceptibility of RSV infection 
(94, 120-122).  However, genetic variation of the host is believed to be the greatest 
influence on response and susceptibility to RSV.  The genetics of RSV susceptibility and 
immune response has been heavily investigated using the candidate gene approach.  
Using this technique many genes were found to be associated with RSV infection, 
including CCR5 (C-C chemokines receptor type 5), Il8 (Interleukin-8), IL4 (Interleukin-
4), IL9 (Interleukin-9), IL10 (Interleukin-10), TNFα (Tumor necrosis factor-α) and TLR4 
(Toll-like recptor 4) (93, 103, 123-128).  One gene that is well characterized in respects 
to RSV infection is Tlr4.  In various studies C3H/HeJ mice, which have a Tlr4 mutation, 
were found to be resistant and relatively non-responsive to RSV infection (129, 130); 
C3H/HeOuJ mice have a fully functional Tlr4 gene and present severe pulmonary 
inflammation after infection.  Because the only difference between these two strains is 
Tlr4, it is believed that Tlr4 is responsible for RSV disease phenotypes in mice.  A 
number of studies have found that polymorphisms in TLR4 are associated with RSV 
disease severity in humans, though the mechanism(s) though which this effect occurs is 
not understood (127, 131-133). 
Studies using inbred mouse strains have confirmed that susceptibility to infection 
is influenced by genetic background of the individual.  Furthermore, in vivo and 
epidemiology studies indicate that susceptibility to RSV is multigenic (129, 130, 134, 
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135).  Further in vivo studies using either recombinant inbred strains or F1 progeny found 
that susceptibility to RSV infection is a heritable trait (130, 135).  Recently the positional 
cloning approach has linked a variety of genes to RSV susceptibility (135).  This 
approach revealed that initial response to RSV primarily involves early antiviral defense 
changes, including genes associated with T-cell differentiation, antigen presentation, 
innate immune response, and early response to virus.  For example, essential transcription 
factors responsible for virus-induced transcription such as Stat1 (Signal Transducers and 
Activator of Transcription 1), Stat2 ((Signal Transducers and Activator of Transcription 
2), and chemokines Cxcl10 (C-X-C motif ligand 10), Ccl1 (C-C ligand 1), Ccl4 (C-C 
ligand 4) were associated with RSV susceptibility.  Associations were also found with 
antiviral genes including Adar (adenosine deaminase, RNA-specific), Mx1 (myxovirus 
resistance 1), Mx2 (myxovirus resistance 2), Oas1a (2'-5' oligoadenylate synthetase 1A), 
and Tyki (thymidylate kinase) (135).  This study only investigated associations between 
genetic markers and susceptibility to RSV, which was determined by viral titers.  Due to 
its complexity the investigators did not attempt to determine the genes that regulate 
response to RSV, and to date no study has used positional cloning to identify the genes 
responsible for RSV-induced disease phenotypes.  Despite the amount of research 
dedicated to identifying the gene(s) responsible for RSV susceptibility and response, the 
exact cascade of events remains unknown. 
 
Objective of Chapters 3 - 6  
 Considering that RSV bronchiolitis is the leading cause of infant hospitalizations 
worldwide, and 100% of the population will be infected with RSV at some point in their 
life, it is important to identify the genetic profiles that cause some individuals to be more 
susceptible than others.  If the exact genetic profiles were known, specific and more 
effective prophylactic treatments could be developed.  Therefore, the overall objective of 
Chapters 3 and 4 were to, first, characterize RSV disease phenotypes across multiple 
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inbred strains of mice to model variation in human disease and, second, use positional 
cloning to identifying the genes that regulate response to RSV infection. 
 
Overall Objective of the Dissertation 
 Oxidant stress and inflammation are common characteristics of pulmonary 
responses to air pollutant and viral exposures.  The overall objective of this project was 
two-fold.  The first objective was to utilize a multi-disciplinary approach to investigate 
the role of a candidate susceptibility gene (Cx3cr1) in response to ozone and, 
subsequently, to RSV.  The second objective was to utilize a positional cloning approach 
to identify genes that contribute to RSV disease phenotypes.  It was hypothesized that 
these studies would identify mechanisms related to oxidative stress and inflammation 
may be common to ozone and RSV disease. 
 
 
 
 16
References 
 
1. Sies, H., and E. Cadenas. 1985. Oxidative stress: damage to intact cells and 
organs. Philos Trans R Soc Lond B Biol Sci 311(1152):617-31. 
2. Cadenas, E., and H. Sies. 1985. Oxidative stress: excited oxygen species and 
enzyme activity. Adv Enzyme Regul 23:217-37. 
3. Gutteridge, J. M., and B. Halliwell. 2000. Free radicals and antioxidants in the 
year 2000. A historical look to the future. Ann N Y Acad Sci 899:136-47. 
4. Halliwell, B., J. M. Gutteridge, and C. E. Cross. 1992. Free radicals, antioxidants, 
and human disease: where are we now? J Lab Clin Med 119(6):598-620. 
5. MacNee, W. 2001. Oxidative stress and lung inflammation in airways disease. 
Eur J Pharmacol 429(1-3):195-207. 
6. Repine, J. E., A. Bast, and I. Lankhorst. 1997. Oxidative stress in chronic 
obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care 
Med 156(2 Pt 1):341-57. 
7. Kay, A. B. 1991. Asthma and inflammation. J Allergy Clin Immunol 87(5):893-
910. 
8. Bousquet, J., P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola. 2000. 
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir 
Crit Care Med 161(5):1720-45. 
9. Dworski, R., L. J. Roberts, 2nd, J. J. Murray, J. D. Morrow, T. V. Hartert, and J. 
R. Sheller. 2001. Assessment of oxidant stress in allergic asthma by measurement of the 
major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp 
Allergy 31(3):387-90. 
10. Calhoun, W. J., and R. K. Bush. 1990. Enhanced reactive oxygen species 
metabolism of airspace cells and airway inflammation follow antigen challenge in human 
asthma. J Allergy Clin Immunol 86(3 Pt 1):306-13. 
 17
11. Calhoun, W. J., H. E. Reed, D. R. Moest, and C. A. Stevens. 1992. Enhanced 
superoxide production by alveolar macrophages and air-space cells, airway inflammation, 
and alveolar macrophage density changes after segmental antigen bronchoprovocation in 
allergic subjects. Am Rev Respir Dis 145(2 Pt 1):317-25. 
12. Smith, L. J., M. Shamsuddin, P. H. Sporn, M. Denenberg, and J. Anderson. 1997. 
Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic Biol Med 
22(7):1301-7. 
13. Monteseirin, J., I. Bonilla, J. Camacho, J. Conde, and F. Sobrino. 2001. Elevated 
secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of 
immunotherapy. J Allergy Clin Immunol 107(4):623-6. 
14. Aldridge, R. E., T. Chan, C. J. van Dalen, R. Senthilmohan, M. Winn, P. Venge, 
G. I. Town, and A. J. Kettle. 2002. Eosinophil peroxidase produces hypobromous acid in 
the airways of stable asthmatics. Free Radic Biol Med 33(6):847-56. 
15. Lee, K. S., S. R. Kim, S. J. Park, H. S. Park, K. H. Min, M. H. Lee, S. M. Jin, G. 
Y. Jin, W. H. Yoo, and Y. C. Lee. 2006. Hydrogen peroxide induces vascular 
permeability via regulation of vascular endothelial growth factor. Am J Respir Cell Mol 
Biol 35(2):190-7. 
16. Adam, L., M. Bouvier, and T. L. Jones. 1999. Nitric oxide modulates beta(2)-
adrenergic receptor palmitoylation and signaling. J Biol Chem 274(37):26337-43. 
17. Owen, S., D. Pearson, V. Suarez-Mendez, R. O'Driscoll, and A. Woodcock. 1991. 
Evidence of free-radical activity in asthma. N Engl J Med 325(8):586-7. 
18. Krishna, M. T., A. J. Chauhan, A. J. Frew, and S. T. Holgate. 1998. Toxicological 
mechanisms underlying oxidant pollutant-induced airway injury. Rev Environ Health 
13(1-2):59-71. 
19. Schauer, U., C. Leinhaas, R. Jager, and C. H. Rieger. 1991. Enhanced superoxide 
generation by eosinophils from asthmatic children. Int Arch Allergy Appl Immunol 
96(4):317-21. 
20. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. 
Lamy, J. R. Legall, A. Morris, and R. Spragg. 1994. The American-European Consensus 
Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial 
coordination. Am J Respir Crit Care Med 149(3 Pt 1):818-24. 
 18
21. Siler, T. M., J. E. Swierkosz, T. M. Hyers, A. A. Fowler, and R. O. Webster. 
1989. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients 
and patients with the adult respiratory distress syndrome. Exp Lung Res 15(6):881-94. 
22. Kietzmann, D., R. Kahl, M. Muller, H. Burchardi, and D. Kettler. 1993. Hydrogen 
peroxide in expired breath condensate of patients with acute respiratory failure and with 
ARDS. Intensive Care Med 19(2):78-81. 
23. Ware, L. B. 2006. Pathophysiology of acute lung injury and the acute respiratory 
distress syndrome. Semin Respir Crit Care Med 27(4):337-49. 
24. Holz, O., R. A. Jorres, P. Timm, M. Mucke, K. Richter, S. Koschyk, and H. 
Magnussen. 1999. Ozone-induced airway inflammatory changes differ between 
individuals and are reproducible. Am J Respir Crit Care Med 159(3):776-84. 
25. Beckman, J. S., J. Chen, H. Ischiropoulos, and J. P. Crow. 1994. Oxidative 
chemistry of peroxynitrite. Methods Enzymol 233:229-40. 
26. Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the 
pathophysiology of acute respiratory distress syndrome. J Pathol 202(2):145-56. 
27. Spektor, D. M., M. Lippmann, P. J. Lioy, G. D. Thurston, K. Citak, D. J. James, 
N. Bock, F. E. Speizer, and C. Hayes. 1988. Effects of ambient ozone on respiratory 
function in active, normal children. Am Rev Respir Dis 137(2):313-20. 
28. Horstman, D. H., L. J. Folinsbee, P. J. Ives, S. Abdul-Salaam, and W. F. 
McDonnell. 1990. Ozone concentration and pulmonary response relationships for 6.6-
hour exposures with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm. Am Rev 
Respir Dis 142(5):1158-63. 
29. Thurston, G. D., M. Lippmann, M. B. Scott, and J. M. Fine. 1997. Summertime 
haze air pollution and children with asthma. Am J Respir Crit Care Med 155(2):654-60. 
30. Krishna, M. T., J. Madden, L. M. Teran, G. L. Biscione, L. C. Lau, N. J. Withers, 
T. Sandstrom, I. Mudway, F. J. Kelly, A. Walls, A. J. Frew, and S. T. Holgate. 1998. 
Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid 
and bronchial mucosa of healthy subjects. Eur Respir J 11(6):1294-300. 
 19
31. Altshuller, A. P. 1987. Estimation of the natural background of ozone present at 
surface rural locations. Japca 37(12):1409-17. 
32. Lippmann, M. 1993. Health effects of tropospheric ozone: review of recent 
research findings and their implications to ambient air quality standards. J Expo Anal 
Environ Epidemiol 3(1):103-29. 
33. Mudway, I. S., M. T. Krishna, A. J. Frew, D. MacLeod, T. Sandstrom, S. T. 
Holgate, and F. J. Kelly. 1999. Compromised concentrations of ascorbate in fluid lining 
the respiratory tract in human subjects after exposure to ozone. Occup Environ Med 
56(7):473-81. 
34. Stenfors, N., J. Pourazar, A. Blomberg, M. T. Krishna, I. Mudway, R. Helleday, 
F. J. Kelly, A. J. Frew, and T. Sandstrom. 2002. Effect of ozone on bronchial mucosal 
inflammation in asthmatic and healthy subjects. Respir Med 96(5):352-8. 
35. Avissar, N. E., C. K. Reed, C. Cox, M. W. Frampton, and J. N. Finkelstein. 2000. 
Ozone, but not nitrogen dioxide, exposure decreases glutathione peroxidases in epithelial 
lining fluid of human lung. Am J Respir Crit Care Med 162(4 Pt 1):1342-7. 
36. Reddy, A. K., R. E. Kimball, and S. T. Omaye. 1986. Selected pulmonary 
biochemical and hematological changes produced by prolonged hypoxia in the rat. Exp 
Mol Pathol 45(3):336-42. 
37. Timblin, C., K. BeruBe, A. Churg, K. Driscoll, T. Gordon, D. Hemenway, E. 
Walsh, A. B. Cummins, P. Vacek, and B. Mossman. 1998. Ambient particulate matter 
causes activation of the c-jun kinase/stress-activated protein kinase cascade and DNA 
synthesis in lung epithelial cells. Cancer Res 58(20):4543-7. 
38. Fakhrzadeh, L., J. D. Laskin, and D. L. Laskin. 2004. Ozone-induced production 
of nitric oxide and TNF-alpha and tissue injury are dependent on NF-kappaB p50. Am J 
Physiol Lung Cell Mol Physiol 287(2):L279-85. 
39. Salvi, S. 2001. Pollution and allergic airways disease. Curr Opin Allergy Clin 
Immunol 1(1):35-41. 
40. Frampton, M. W., W. A. Pryor, R. Cueto, C. Cox, P. E. Morrow, and M. J. Utell. 
1999. Aldehydes (nonanal and hexanal) in rat and human bronchoalveolar lavage fluid 
after ozone exposure. Res Rep Health Eff Inst(90):1-15; discussion 17-8. 
 20
41. Frampton, M. W., W. A. Pryor, R. Cueto, C. Cox, P. E. Morrow, and M. J. Utell. 
1999. Ozone exposure increases aldehydes in epithelial lining fluid in human lung. Am J 
Respir Crit Care Med 159(4 Pt 1):1134-7. 
42. Pryor, W. A., G. L. Squadrito, and M. Friedman. 1995. The cascade mechanism 
to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med 
19(6):935-41. 
43. Hoffman, M., S. R. Feldman, and S. V. Pizzo. 1983. Alpha 2-macroglobulin 'fast' 
forms inhibit superoxide production by activated macrophages. Biochim Biophys Acta 
760(3):421-3. 
44. Kafoury, R. M., W. A. Pryor, G. L. Squadrito, M. G. Salgo, X. Zou, and M. 
Friedman. 1999. Induction of inflammatory mediators in human airway epithelial cells by 
lipid ozonation products. Am J Respir Crit Care Med 160(6):1934-42. 
45. Voter, K. Z., J. C. Whitin, A. Torres, P. E. Morrow, C. Cox, Y. Tsai, M. J. Utell, 
and M. W. Frampton. 2001. Ozone exposure and the production of reactive oxygen 
species by bronchoalveolar cells in humans. Inhal Toxicol 13(6):465-83. 
46. Yang, W., and S. T. Omaye. 2009. Air pollutants, oxidative stress and human 
health. Mutat Res 674(1-2):45-54. 
47. Howden, R., E. Liu, L. Miller-DeGraff, H. L. Keener, C. Walker, J. A. Clark, P. 
H. Myers, D. C. Rouse, T. Wiltshire, and S. R. Kleeberger. 2008. The genetic 
contribution to heart rate and heart rate variability in quiescent mice. Am J Physiol Heart 
Circ Physiol 295(1):H59-68. 
48. Annesi-Maesano, I., N. Agabiti, R. Pistelli, M. F. Couilliot, and F. Forastiere. 
2003. Subpopulations at increased risk of adverse health outcomes from air pollution. Eur 
Respir J Suppl 40:57s-63s. 
49. McDonnell, W. F., 3rd, D. H. Horstman, S. Abdul-Salaam, and D. E. House. 
1985. Reproducibility of individual responses to ozone exposure. Am Rev Respir Dis 
131(1):36-40. 
50. Dawn Teare, M., and J. H. Barrett. 2005. Genetic linkage studies. Lancet 
366(9490):1036-44. 
 21
51. Lander, E. S., and N. J. Schork. 1994. Genetic dissection of complex traits. 
Science 265(5181):2037-48. 
52. Cordell, H. J., and D. G. Clayton. 2005. Genetic association studies. Lancet 
366(9491):1121-31. 
53. Kleeberger, S. R. 2003. Genetic aspects of susceptibility to air pollution. Eur 
Respir J Suppl 40:52s-56s. 
54. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. 
Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall, and O. Yoshie. 1997. Identification and 
molecular characterization of fractalkine receptor CX3CR1, which mediates both 
leukocyte migration and adhesion. Cell 91(4):521-30. 
55. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. 
Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine 
with a CX3C motif. Nature 385(6617):640-4. 
56. Kanazawa, N., T. Nakamura, K. Tashiro, M. Muramatsu, K. Morita, K. Yoneda, 
K. Inaba, S. Imamura, and T. Honjo. 1999. Fractalkine and macrophage-derived 
chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur J 
Immunol 29(6):1925-32. 
57. Pan, Y., C. Lloyd, H. Zhou, S. Dolich, J. Deeds, J. A. Gonzalo, J. Vath, M. 
Gosselin, J. Ma, B. Dussault, E. Woolf, G. Alperin, J. Culpepper, J. C. Gutierrez-Ramos, 
and D. Gearing. 1997. Neurotactin, a membrane-anchored chemokine upregulated in 
brain inflammation. Nature 387(6633):611-7. 
58. Kasama, T., K. Wakabayashi, M. Sato, R. Takahashi, and T. Isozaki. Relevance 
of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy. Transl Res 
155(1):20-6. 
59. Zhao, R., Y. Wang, R. Shen, and Y. Sun. Relationship Between CX3CR1 Genetic 
Polymorphism and Carotid Atherosclerosis. Artif Cells Blood Substit Immobil Biotechnol. 
60. Husberg, C., S. Nygard, A. V. Finsen, J. K. Damas, A. Frigessi, E. Oie, A. 
Waehre, L. Gullestad, P. Aukrust, A. Yndestad, and G. Christensen. 2008. Cytokine 
expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart 
failure. J Mol Cell Cardiol 45(2):261-9. 
 22
61. Parczewski, M., M. Leszczyszyn-Pynka, M. Kaczmarczyk, G. Adler, A. Binczak-
Kuleta, B. Loniewska, A. Boron-Kaczmarska, and A. Ciechanowicz. 2009. Sequence 
variants of chemokine receptor genes and susceptibility to HIV-1 infection. J Appl Genet 
50(2):159-66. 
62. McDermott, D. H., J. S. Colla, C. A. Kleeberger, M. Plankey, P. S. Rosenberg, E. 
D. Smith, P. A. Zimmerman, C. Combadiere, S. F. Leitman, R. A. Kaslow, J. J. Goedert, 
E. A. Berger, T. R. O'Brien, and P. M. Murphy. 2000. Genetic polymorphism in 
CX3CR1 and risk of HIV disease. Science 290(5499):2031. 
63. MacFie, T. S., E. Nerrienet, N. G. de Groot, R. E. Bontrop, and N. I. Mundy. 
2009. Patterns of diversity in HIV-related loci among subspecies of chimpanzee: 
concordance at CCR5 and differences at CXCR4 and CX3CR1. Mol Biol Evol 26(4):719-
27. 
64. Faure, S., L. Meyer, D. Costagliola, C. Vaneensberghe, E. Genin, B. Autran, J. F. 
Delfraissy, D. H. McDermott, P. M. Murphy, P. Debre, I. Theodorou, and C. 
Combadiere. 2000. Rapid progression to AIDS in HIV+ individuals with a structural 
variant of the chemokine receptor CX3CR1. Science 287(5461):2274-7. 
65. McComb, J. G., M. Ranganathan, X. H. Liu, J. M. Pilewski, P. Ray, S. C. 
Watkins, A. M. Choi, and J. S. Lee. 2008. CX3CL1 up-regulation is associated with 
recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs 
during cigarette smoke-induced emphysema. Am J Pathol 173(4):949-61. 
66. Bourgeois, C., J. B. Bour, K. Lidholt, C. Gauthray, and P. Pothier. 1998. Heparin-
like structures on respiratory syncytial virus are involved in its infectivity in vitro. J Virol 
72(9):7221-7. 
67. Feldman, S. A., R. M. Hendry, and J. A. Beeler. 1999. Identification of a linear 
heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. 
J Virol 73(8):6610-7. 
68. Tripp, R. A. 2004. Pathogenesis of respiratory syncytial virus infection. Viral 
Immunol 17(2):165-81. 
69. Ogra, P. L. 2004. Respiratory syncytial virus: the virus, the disease and the 
immune response. Paediatr Respir Rev 5 Suppl A:S119-26. 
 23
70. Henrickson, K. J., S. Hoover, K. S. Kehl, and W. Hua. 2004. National disease 
burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr 
Infect Dis J 23(1 Suppl):S11-8. 
71. Stein, R. T., D. Sherrill, W. J. Morgan, C. J. Holberg, M. Halonen, L. M. Taussig, 
A. L. Wright, and F. D. Martinez. 1999. Respiratory syncytial virus in early life and risk 
of wheeze and allergy by age 13 years. Lancet 354(9178):541-5. 
72. Silvestri, M., F. Sabatini, A. C. Defilippi, and G. A. Rossi. 2004. The wheezy 
infant -- immunological and molecular considerations. Paediatr Respir Rev 5 Suppl 
A:S81-7. 
73. Martinez, F. D., A. L. Wright, L. M. Taussig, C. J. Holberg, M. Halonen, and W. 
J. Morgan. 1995. Asthma and wheezing in the first six years of life. The Group Health 
Medical Associates. N Engl J Med 332(3):133-8. 
74. Shay, D. K., R. C. Holman, R. D. Newman, L. L. Liu, J. W. Stout, and L. J. 
Anderson. 1999. Bronchiolitis-associated hospitalizations among US children, 1980-
1996. Jama 282(15):1440-6. 
75. Glezen, W. P., L. H. Taber, A. L. Frank, and J. A. Kasel. 1986. Risk of primary 
infection and reinfection with respiratory syncytial virus. Am J Dis Child 140(6):543-6. 
76. Hall, C. B., K. R. Powell, N. E. MacDonald, C. L. Gala, M. E. Menegus, S. C. 
Suffin, and H. J. Cohen. 1986. Respiratory syncytial viral infection in children with 
compromised immune function. N Engl J Med 315(2):77-81. 
77. Openshaw, P. J., G. S. Dean, and F. J. Culley. 2003. Links between respiratory 
syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. 
Pediatr Infect Dis J 22(2 Suppl):S58-64; discussion S64-5. 
78. Ruuskanen, O., and P. L. Ogra. 1993. Respiratory syncytial virus. Curr Probl 
Pediatr 23(2):50-79. 
79. Williams, J. V., P. A. Harris, S. J. Tollefson, L. L. Halburnt-Rush, J. M. 
Pingsterhaus, K. M. Edwards, P. F. Wright, and J. E. Crowe, Jr. 2004. Human 
metapneumovirus and lower respiratory tract disease in otherwise healthy infants and 
children. N Engl J Med 350(5):443-50. 
 24
80. Parrott, R. H., H. W. Kim, J. O. Arrobio, D. S. Hodes, B. R. Murphy, C. D. 
Brandt, E. Camargo, and R. M. Chanock. 1973. Epidemiology of respiratory syncytial 
virus infection in Washington, D.C. II. Infection and disease with respect to age, 
immunologic status, race and sex. Am J Epidemiol 98(4):289-300. 
81. Falsey, A. R., P. A. Hennessey, M. A. Formica, C. Cox, and E. E. Walsh. 2005. 
Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 
352(17):1749-59. 
82. Falsey, A. R., and E. E. Walsh. 2000. Respiratory syncytial virus infection in 
adults. Clin Microbiol Rev 13(3):371-84. 
83. Walsh, E. E., A. R. Falsey, and P. A. Hennessey. 1999. Respiratory syncytial and 
other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit 
Care Med 160(3):791-5. 
84. Murphy, B. R., G. A. Prince, E. E. Walsh, H. W. Kim, R. H. Parrott, V. G. 
Hemming, W. J. Rodriguez, and R. M. Chanock. 1986. Dissociation between serum 
neutralizing and glycoprotein antibody responses of infants and children who received 
inactivated respiratory syncytial virus vaccine. J Clin Microbiol 24(2):197-202. 
85. Murphy, B. R., and E. E. Walsh. 1988. Formalin-inactivated respiratory syncytial 
virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-
inhibiting activity. J Clin Microbiol 26(8):1595-7. 
86. Hall, C. B., E. E. Walsh, C. E. Long, and K. C. Schnabel. 1991. Immunity to and 
frequency of reinfection with respiratory syncytial virus. J Infect Dis 163(4):693-8. 
87. Kim, H. W., J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock, K. Jensen, 
and R. H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior 
administration of antigenic inactivated vaccine. Am J Epidemiol 89(4):422-34. 
88. Tang, Y. W., and B. S. Graham. 1994. Anti-IL-4 treatment at immunization 
modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte 
activity in mice challenged with respiratory syncytial virus. J Clin Invest 94(5):1953-8. 
89. Zhang, W., Y. Choi, L. M. Haynes, J. L. Harcourt, L. J. Anderson, L. P. Jones, 
and R. A. Tripp. 2009. Vaccination to Induce Antibodies Blocking RSV G Protein 
CX3C-CX3CR1 Interaction Reduces Pulmonary Inflammation and Virus Replication in 
Mice. J Virol. 
 25
90. Holberg, C. J., A. L. Wright, F. D. Martinez, C. G. Ray, L. M. Taussig, and M. D. 
Lebowitz. 1991. Risk factors for respiratory syncytial virus-associated lower respiratory 
illnesses in the first year of life. Am J Epidemiol 133(11):1135-51. 
91. Hacimustafaoglu, M., S. Celebi, E. Aynaci, M. Sinirtas, N. Koksal, A. 
Kucukerdogan, I. Ercan, G. Goral, and I. Ildirim. 2004. The progression of maternal RSV 
antibodies in the offspring. Arch Dis Child 89(1):52-3. 
92. Sigurs, N., R. Bjarnason, F. Sigurbergsson, and B. Kjellman. 2000. Respiratory 
syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy 
at age 7. Am J Respir Crit Care Med 161(5):1501-7. 
93. Choi, E. H., H. J. Lee, T. Yoo, and S. J. Chanock. 2002. A common haplotype of 
interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in 
Korean children. J Infect Dis 186(9):1207-11. 
94. Simoes, E. A. 2008. RSV disease in the pediatric population: epidemiology, 
seasonal variability, and long-term outcomes. Manag Care 17(11 Suppl 12):3-6, 
discussion 18-9. 
95. Hussell, T., C. J. Baldwin, A. O'Garra, and P. J. Openshaw. 1997. CD8+ T cells 
control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur 
J Immunol 27(12):3341-9. 
96. Johnson, J. E., R. A. Gonzales, S. J. Olson, P. F. Wright, and B. S. Graham. 2007. 
The histopathology of fatal untreated human respiratory syncytial virus infection. Mod 
Pathol 20(1):108-19. 
97. Johnson, T. R., S. Hong, L. Van Kaer, Y. Koezuka, and B. S. Graham. 2002. NK 
T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune 
responses to respiratory syncytial virus. J Virol 76(9):4294-303. 
98. Welliver, T. P., R. P. Garofalo, Y. Hosakote, K. H. Hintz, L. Avendano, K. 
Sanchez, L. Velozo, H. Jafri, S. Chavez-Bueno, P. L. Ogra, L. McKinney, J. L. Reed, and 
R. C. Welliver, Sr. 2007. Severe human lower respiratory tract illness caused by 
respiratory syncytial virus and influenza virus is characterized by the absence of 
pulmonary cytotoxic lymphocyte responses. J Infect Dis 195(8):1126-36. 
 26
99. Hussell, T., L. C. Spender, A. Georgiou, A. O'Garra, and P. J. Openshaw. 1996. 
Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory 
syncytial virus. J Gen Virol 77 ( Pt 10):2447-55. 
100. Li, L., H. H. Lee, J. J. Bell, R. K. Gregg, J. S. Ellis, A. Gessner, and H. 
Zaghouani. 2004. IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and 
skews neonatal immunity toward Th2. Immunity 20(4):429-40. 
101. Hussell, T., U. Khan, and P. Openshaw. 1997. IL-12 treatment attenuates T helper 
cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness. J 
Immunol 159(1):328-34. 
102. Rudd, B. D., J. J. Smit, R. A. Flavell, L. Alexopoulou, M. A. Schaller, A. Gruber, 
A. A. Berlin, and N. W. Lukacs. 2006. Deletion of TLR3 alters the pulmonary immune 
environment and mucus production during respiratory syncytial virus infection. J 
Immunol 176(3):1937-42. 
103. Hoebee, B., L. Bont, E. Rietveld, M. van Oosten, H. M. Hodemaekers, N. J. 
Nagelkerke, H. J. Neijens, J. L. Kimpen, and T. G. Kimman. 2004. Influence of promoter 
variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on 
respiratory syncytial virus bronchiolitis. J Infect Dis 189(2):239-47. 
104. Wilson, J., K. Rowlands, K. Rockett, C. Moore, E. Lockhart, M. Sharland, D. 
Kwiatkowski, and J. Hull. 2005. Genetic variation at the IL10 gene locus is associated 
with severity of respiratory syncytial virus bronchiolitis. J Infect Dis 191(10):1705-9. 
105. Tekkanat, K. K., H. Maassab, A. Miller, A. A. Berlin, S. L. Kunkel, and N. W. 
Lukacs. 2002. RANTES (CCL5) production during primary respiratory syncytial virus 
infection exacerbates airway disease. Eur J Immunol 32(11):3276-84. 
106. De Weerd, W., W. N. Twilhaar, and J. L. Kimpen. 1998. T cell subset analysis in 
peripheral blood of children with RSV bronchiolitis. Scand J Infect Dis 30(1):77-80. 
107. Roman, M., W. J. Calhoun, K. L. Hinton, L. F. Avendano, V. Simon, A. M. 
Escobar, A. Gaggero, and P. V. Diaz. 1997. Respiratory syncytial virus infection in 
infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 
156(1):190-5. 
 27
108. van Schaik, S. M., N. Obot, G. Enhorning, K. Hintz, K. Gross, G. E. Hancock, A. 
M. Stack, and R. C. Welliver. 2000. Role of interferon gamma in the pathogenesis of 
primary respiratory syncytial virus infection in BALB/c mice. J Med Virol 62(2):257-66. 
109. Bolger, G., N. Lapeyre, N. Dansereau, L. Lagace, G. Berry, K. Klosowski, T. 
Mewhort, and M. Liuzzi. 2005. Primary infection of mice with high titer inoculum 
respiratory syncytial virus: characterization and response to antiviral therapy. Can J 
Physiol Pharmacol 83(2):198-213. 
110. Cho, H. Y., F. Imani, L. Miller-DeGraff, D. Walters, G. A. Melendi, M. 
Yamamoto, F. P. Polack, and S. R. Kleeberger. 2009. Antiviral activity of Nrf2 in a 
murine model of respiratory syncytial virus disease. Am J Respir Crit Care Med 
179(2):138-50. 
111. Hosakote, Y. M., T. Liu, S. M. Castro, R. P. Garofalo, and A. Casola. 2009. 
Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. 
Am J Respir Cell Mol Biol 41(3):348-57. 
112. Mochizuki, H., M. Todokoro, and H. Arakawa. 2009. RS virus-induced 
inflammation and the intracellular glutathione redox state in cultured human airway 
epithelial cells. Inflammation 32(4):252-64. 
113. van Schaik, S. M., D. A. Tristram, I. S. Nagpal, K. M. Hintz, R. C. Welliver, 2nd, 
and R. C. Welliver. 1999. Increased production of IFN-gamma and cysteinyl leukotrienes 
in virus-induced wheezing. J Allergy Clin Immunol 103(4):630-6. 
114. Cho, H. Y., A. E. Jedlicka, S. P. Reddy, T. W. Kensler, M. Yamamoto, L. Y. 
Zhang, and S. R. Kleeberger. 2002. Role of NRF2 in protection against hyperoxic lung 
injury in mice. Am J Respir Cell Mol Biol 26(2):175-82. 
115. Devincenzo, J. P. 2004. Natural infection of infants with respiratory syncytial 
virus subgroups A and B: a study of frequency, disease severity, and viral load. Pediatr 
Res 56(6):914-7. 
116. Mufson, M. A., B. Akerlind-Stopner, C. Orvell, R. B. Belshe, and E. Norrby. 
1991. A single-season epidemic with respiratory syncytial virus subgroup B2 during 10 
epidemic years, 1978 to 1988. J Clin Microbiol 29(1):162-5. 
117. Kamasaki, H., H. Tsutsumi, K. Seki, and S. Chiba. 2001. Genetic variability of 
respiratory syncytial virus subgroup B strain isolated during the last 20 years from the 
 28
same region in Japan: existence of time-dependent linear genetic drifts. Arch Virol 
146(3):457-66. 
118. Seki, K., H. Tsutsumi, M. Ohsaki, H. Kamasaki, and S. Chiba. 2001. Genetic 
variability of respiratory syncytial virus subgroup a strain in 15 successive epidemics in 
one city. J Med Virol 64(3):374-80. 
119. Kuroiwa, Y., K. Nagai, L. Okita, and H. Tsutsumi. 2004. Genetic variability and 
molecular epidemiology of respiratory syncytial virus subgroup a strains in Japan 
determined by heteroduplex mobility assay. J Clin Microbiol 42(5):2048-53. 
120. Wilfret, D. A., B. T. Baker, E. Palavecino, C. Moran, and D. K. Benjamin, Jr. 
2008. Epidemiology of respiratory syncytial virus in various regions within North 
Carolina during multiple seasons. N C Med J 69(6):447-52. 
121. Stensballe, L. G., H. Ravn, K. Kristensen, T. Meakins, P. Aaby, and E. A. 
Simoes. 2009. Seasonal variation of maternally derived respiratory syncytial virus 
antibodies and association with infant hospitalizations for respiratory syncytial virus. J 
Pediatr 154(2):296-8. 
122. Murdoch, D. R., and L. C. Jennings. 2009. Association of respiratory virus 
activity and environmental factors with the incidence of invasive pneumococcal disease. 
J Infect 58(1):37-46. 
123. Hacking, D., J. C. Knight, K. Rockett, H. Brown, J. Frampton, D. P. 
Kwiatkowski, J. Hull, and I. A. Udalova. 2004. Increased in vivo transcription of an IL-8 
haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun 
5(4):274-82. 
124. Hull, J., K. Rowlands, E. Lockhart, M. Sharland, C. Moore, N. Hanchard, and D. 
P. Kwiatkowski. 2004. Haplotype mapping of the bronchiolitis susceptibility locus near 
IL8. Hum Genet 114(3):272-9. 
125. Hull, J., K. Rowlands, E. Lockhart, C. Moore, M. Sharland, and D. Kwiatkowski. 
2003. Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis 
caused by respiratory syncytial virus. J Infect Dis 188(6):904-7. 
126. Goetghebuer, T., K. Isles, C. Moore, A. Thomson, D. Kwiatkowski, and J. Hull. 
2004. Genetic predisposition to wheeze following respiratory syncytial virus 
bronchiolitis. Clin Exp Allergy 34(5):801-3. 
 29
127. Tal, G., A. Mandelberg, I. Dalal, K. Cesar, E. Somekh, A. Tal, A. Oron, S. 
Itskovich, A. Ballin, S. Houri, A. Beigelman, O. Lider, G. Rechavi, and N. Amariglio. 
2004. Association between common Toll-like receptor 4 mutations and severe respiratory 
syncytial virus disease. J Infect Dis 189(11):2057-63. 
128. Hoebee, B., E. Rietveld, L. Bont, M. Oosten, H. M. Hodemaekers, N. J. 
Nagelkerke, H. J. Neijens, J. L. Kimpen, and T. G. Kimman. 2003. Association of severe 
respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor 
alpha polymorphisms. J Infect Dis 187(1):2-11. 
129. Prince, G. A., R. L. Horswood, J. Berndt, S. C. Suffin, and R. M. Chanock. 1979. 
Respiratory syncytial virus infection in inbred mice. Infect Immun 26(2):764-6. 
130. Stark, J. M., S. A. McDowell, V. Koenigsknecht, D. R. Prows, J. E. Leikauf, A. 
M. Le Vine, and G. D. Leikauf. 2002. Genetic susceptibility to respiratory syncytial virus 
infection in inbred mice. J Med Virol 67(1):92-100. 
131. Awomoyi, A. A., P. Rallabhandi, T. I. Pollin, E. Lorenz, M. B. Sztein, M. S. 
Boukhvalova, V. G. Hemming, J. C. Blanco, and S. N. Vogel. 2007. Association of 
TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk 
infants and young children. J Immunol 179(5):3171-7. 
132. Tulic, M. K., R. J. Hurrelbrink, C. M. Prele, I. A. Laing, J. W. Upham, P. Le 
Souef, P. D. Sly, and P. G. Holt. 2007. TLR4 polymorphisms mediate impaired responses 
to respiratory syncytial virus and lipopolysaccharide. J Immunol 179(1):132-40. 
133. Puthothu, B., J. Forster, A. Heinzmann, and M. Krueger. 2006. TLR-4 and CD14 
polymorphisms in respiratory syncytial virus associated disease. Dis Markers 22(5-
6):303-8. 
134. Byrd, L. G., and G. A. Prince. 1997. Animal models of respiratory syncytial virus 
infection. Clin Infect Dis 25(6):1363-8. 
135. Stark, J. M., M. M. Barmada, A. V. Winterberg, N. Majumber, W. J. Gibbons, Jr., 
M. A. Stark, M. A. Sartor, M. Medvedovic, J. Kolls, K. Bein, B. Mailaparambil, M. 
Krueger, A. Heinzmann, G. D. Leikauf, and D. R. Prows. 2009. Genomewide association 
analysis of respiratory syncytial virus infection in mice. J Virol. 
 
 
CHAPTER 2 
 
Cx3cr1 CONTRIBUTES TO PULMONARY INFLAMMATION IN THE MOUSE 
 
 
31
Abstract 
 
Background.  Exposure to ozone (O3) causes airway inflammation, lung 
hyperpermeability, and epithelial cell injury.  Enhanced expression of the chemokine 
receptor Cx3cr1 increases leukocyte adhesion, and interleukin-17 (IL-17) is linked to 
neutrophilic mobilization, potentially via CX3CR1.  This study tested the hypothesis that 
Cx3cr1 contributes to O3-induced pulmonary inflammation, and that IL-17 is an effector 
mechanism.  
Methods:  Cx3cr1+/-, Cx3cr1-/-, Il17ra+/+ and Il17ra-/- mice were exposed to air or 0.3 
ppm O3 for 24, 48 or 72 hours.  Bronchoalveolar lavage (BAL) fluid analyzed for total 
protein (a marker of lung permeability) and cell differentials were used to evaluate 
inflammation.  Pulmonary PCNA levels were measured by western blot analysis, and 
immunohistochemistry.  Cytokine IL-17A expression in lung homogenate was analyzed 
by ELISA. 
Results:  Significantly greater BAL protein content and numbers of inflammatory cells 
were found in O3-exposed Cx3cr1+/- mice compared to Cx3cr1-/- mice.  O3-induced IL-
17R mRNA expression was significantly elevated in Cx3cr1+/- mice compared to Cx3cr1-
/-.  Further, significantly greater numbers of neutrophils were found in Il17ra+/+ mice 
compared to Il17ra-/- mice after O3. 
Conclusions:  Results of this study are consistent with the hypothesis that Cx3cr1 and 
IL17ra contribute to the pulmonary inflammatory response to O3.  Moreover, results 
suggest that Cx3cr1 may have a regulatory role in IL-17 expression.  The findings of this 
investigation provide novel insight to mechanisms of pulmonary inflammation induced 
by environmental oxidants. 
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Introduction 
 
 Air pollution is a heterogeneous mixture of particles such as aldehydes, 
peroxyacylnitrites, alkyl nitrites, and photochemical by-products including ozone (O3).  
Ozone causes respiratory neutrophilic inflammation, airway hyperactivity, epithelial cell 
injury, and microvascular permeability.  Individuals with pre-existing inflammatory lung 
disease such as asthma are particularly vulnerable to O3 and are at risk for exacerbations 
(1).  However the precise molecular events that cause the inflammatory response seen 
after O3 exposure are not completely understood. 
A number of studies have focused on the possible roles of chemokines/cytokines 
such as macrophage inflammatory protein-2 (MIP-2), interleukin-8 (IL-8), and RANTES, 
in the pathogenesis of O3-induced lung inflammation and injury (2-6).  Cx3cr1 is known 
to mediate both leukocyte migration and adhesion (7).  Recent studies suggest that 
Cx3cr1 has a role in atherosclerosis, rheumatoid arthritis, coal workers’ pneumoconiosis 
(CWP), and microglial neurotoxicity (8-10).  Polymorphisms within this gene have also 
been linked to rapid progression of AIDS in HIV-positive individuals (11).   
A previous study investigated the role Cx3cr1 plays in lung injury.  Investigators 
found that polymorphisms in Cx3cr1 associated with decreased incidence of CWP.  This 
group concluded that the chemokine receptor Cx3cr1 plays a role in lung injury resulting 
from chronic exposure to coal dust (9).  However, the role of Cx3cr1 in lung injury 
following subacute exposure is still unknown.  While no evidence exists that Cx3cr1 
promotes pulmonary responses to acute oxidant exposures, this gene is expressed in the 
lung and modulates chronic inflammation (e.g. CWP, emphysema), and therefore might 
influence the initiation or development of inflammatory responses in that organ (9, 12).   
Increased expression of MIP-2, IL-1β, TNF-α and neutrophilia are markers of O3-
induced inflammation (5, 13, 14).  Regulation of these events in other disease models has 
been linked to the chemotractant interleukin-17A (IL-17A) (15-17).  IL-17A is secreted 
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by activated memory T cells and binds specifically to homodimeric receptor IL-17R.  
Recent studies found that IL-17R-deficient mice are unable to recruit neutrophils to the 
lung following insult (17).  Earlier studies found that expression of CX3CR1 and IL-17R 
was associated with pulmonary inflammation and injury, however it is not known if 
CX3CR1 and IL-17R are co-dependent during pulmonary inflammation (15, 18, 19).  In 
the present study we tested the hypothesis that Cx3cr1 contributes to O3-induced 
pulmonary inflammation and injury, and does so through upregulation of IL-17R. 
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Material and Methods 
 
Animal and Inhalation Exposure 
Male C57BL/6JCx3cr1+/- and C57BL/6JCx3cr1-/- mice (6-9 wk) were obtained from European 
Mouse Mutant Archive (EMMA) (Munich, Germany).  Due to availability 
C57BL/6JCx3cr1+/- mice were used as genotype controls instead of C57BL/6JCx3cr1+/+ mice, 
preliminary data suggest that both genotypes had a similar pulmonary inflammatory 
response to O3.  In a separate study male C57BL/6JIl17ra+/+ mice were obtained from The 
Jackson Laboratory (Bar Harbor, ME, USA) and C57BL/6JIl17ra+/- (12-14 wk) mice were 
obtained from Taconic Farms Inc (Germantown, NY, USA) by permission from Amgen 
Inc (Thousands Oaks, CA, USA).  Inhalation exposures were done in a barrier facility at 
Alion Science and Technology, Inc, Research Triangle Park, NC.  Mice were placed in 
individual stainless-steel wire cages within a Hazelton 1000 chamber (Lab Products, 
Maywood, NJ) equipped with a charcoal and high-efficiency particulate air–filtered air 
supply.  Mice were exposed to 0.3-ppm O3 or filtered air for 24, 48 or 72 hr (23.5 hr/day) 
as described previously (20).  All animals use was approved by the National Institute of 
Environmental Health Sciences Animal Care and Use Committee. 
 
Lung Bronchoalveolar Lavage Fluid (BALF) and Cell Preparation 
Immediately after 24, 48 or 72 hr exposure to O3 or air, mice were euthanized with 
sodium pentobarbital (104 mg/kg), BAL was performed.  BAL cell differentials and total 
protein concentration (a marker of lung permeability) were determined as previously 
described (20),  The three time points chosen for evaluation of inflammation and injury 
were based on previous investigations that characterized the kinetics of inflammation and 
injury responses to continuous exposure to 0.3 ppm O3.   
 
Lung Tissue Preparation for Histopathology and Immunohistochemistry 
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Left lung lobes were fixed with 10% neutral buffered zinc formalin for 24 hrs.  Proximal 
and distal intrapulmonary axial tissues were excised and embedded in paraffin and 
sectioned (5 µm).  Tissue sections were histochemically stained with hemotoxylin and 
eosin (H&E) for comparison of pathology and injury between genotypes.  The terminal 
bronchioles and alveoli were the primary focus of study because after 48 hrs of exposure 
to 0.3 ppm O3 causes inflammation and epithelial cell sloughing in these regions of the 
mouse lung.   
 
Western Blot Analysis 
PCNA expression was detected in nuclear protein (20 µg) using an anti-PCNA antibody 
(sc-56) in the right lungs from mice exposed to O3 or air was assessed as previously 
described (20).  
 
Cytokine Enzyme-linked Immunosorbent (ELISA) Measurement 
Immunoreactive macrophage inflammatory protein (MIP-2), interleukin-1β (IL-1β), and 
interleukin-17A (IL-17A) were quantified in aliquots of BALF (50 µl) using 
commercially available ELISA kits (R&D Systems), according to the manufacturer’s 
instructions.  Each cytokine quantity was calculated from absorbance at 450 nm using a 
standard curve. 
 
Quantitative Polymerase Chain Reaction (qPCR) 
Total RNA was isolated from non-lavaged left lung pieces RNeasy Mini Kit (Qiagen, 
Valencia, CA) following the manufacturer’s procedure.  One g of total RNA was 
reverse transcribed into cDNA.  For quantitative PCR, an aliquot (1-2.5 l) of cDNA was 
amplified in a 25 l reaction containing 12.5 l 2X PowerSYBR Green Master Mix 
(Applied Biosystems, Foster City, CA) and 250 nM of each gene-specific forward and 
reverse primer by 10 minute hold at 95°C and 45 cycles at 95°C (15 seconds) -60°C (1 
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minute) using the Applied Biosystems StepOne Plus Real-Time PCR Systems.  
Quantification of gene expression was determined by ΔCT values obtained by subtracting 
fluorescence detected number of cycles to threshold (CT) of 18s mRNA from those of 
target gene RNA in the same sample.   
 
Statistics 
Data were expressed as the mean ± SEM.  Two-way analysis of variance (ANOVA) was 
used to evaluate the effects of exposure and genotype in all experiments.  All statistical 
analyses were performed using Sigma-Stat software program (SPSS, INC. Chicago, IL). 
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Results 
Cx3cr1 effect on O3-induced pulmonary inflammation and injury 
The role of Cx3cr1 on O3-induced pulmonary inflammation was examined by 
exposing continuously Cx3cr1+/- and Cx3cr1-/- mice to air or O3 for 24, 48 and 72 hr.  
Significant differences in BAL protein concentration and cell numbers were found 
between genotypes following air exposure (Figure 2.1A).  Relative to respective air 
controls, 48 and 72 hr O3 caused significant increases in mean numbers of BAL 
macrophages, polymorphonuclear leukocytes (PMNs), epithelial cells, and lymphocytes 
in Cx3cr1+/- and Cx3cr1-/- mice.  However, numbers of all cell types were significantly 
greater in Cx3cr1+/- mice compared to Cx3cr1-/- (Figure 2.1).  O3 caused significant 
increases in total BAL protein in Cx3cr1+/- (24, 48, and 72 hr) and Cx3cr1-/- (48 and 72 
hr) mice (Figure 2.1B), but no significant differences in mean total protein were found 
between genotypes at any time points following O3.   
 H&E stained lung sections from Cx3cr1+/- and Cx3cr1-/- air controls were normal, 
and no histological differences were found between them.  Significant peribronchiolar 
inflammation, cellular proliferation, and epithelial hyperplasia were found in terminal 
bronchioles of Cx3cr1+/- and Cx3cr1-/- mice after 48 hr O3 (Figure 2.2).  However, O3-
induced injury in the terminal bronchioles was markedly attenuated in Cx3cr1-/- mice 
compared to Cx3cr1+/-.  Furthermore, O3 enhanced nuclear PCNA expression (an 
indicator of cellular proliferation) in lung homogenates of both genotypes in an exposure-
dependent manner after 48 and 72 hr (Figure 2.3A).  However, PCNA levels were 
significantly attenuated in Cx3cr1-/- mice compared with Cx3cr1+/- mice after O3 (Figure 
2.3A).  Immunostaining for PCNA also indicated that PCNA expression was enhanced in 
Cx3cr1+/- mice relative to exposure-matched Cx3cr1-/- mice (Figure 2.3B). 
 
Influence of Cx3cr1 on O3-induced chemokine expression 
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 To investigate the possible mechanisms through which Cx3cr1 modulates 
pulmonary PMN inflammation, we measured BAL levels of MIP-2 and IL-1β, 
chemokines known to be involved in PMN recruitment.  No significant difference in 
MIP-2 or IL-1 concentration was found between Cx3cr1+/- and Cx3cr1-/- mice after 
exposure to air (Figure 2.4A).  Following O3 exposure, the concentration of MIP-2 was 
increased and was greatest after 48 hrs in both genotypes, but was significantly greater in 
Cx3cr1+/- mice compared to Cx3cr1-/- mice.  IL-1β concentration was significantly 
elevated in Cx3cr1+/- mice following O3, and concentration peaked after 72 hrs O3; 
however, O3 had no effect on IL-1β concentration in Cx3cr1-/- mice (Figure 2.4B).  
Consistent with BAL data and pathology the concentrations of MIP-2 and IL-1β were 
greater in Cx3cr1+/- mice than in Cx3cr1-/- (Figure 2.4). 
 
Effect of Cx3cr1 on expression of IL-17R mRNA 
 IL-17R is critical for the recruitment of neutrophils, and regulates chemokine 
expression in the lung after microbial or particulate challenge.  IL-17R mRNA expression 
was measured to determine if Cx3cr1 modulates O3-induced inflammatory cell migration 
by upregulating IL-17R.  Relative to air controls, IL-17R mRNA expression was 
enhanced in Cx3cr1+/- mice following O3 exposure (Figure 2.5).  Expression of IL-17R 
mRNA in Cx3cr1+/- mice increased significantly after 48 hr O3, and then expression was 
greatly diminished after 72 hr O3, and not significantly different from air controls.  IL-
17R expression also increased significantly in Cx3cr1-/- mice after 48 hr O3 relative to air 
control mice, but expression level was significantly less than that found in Cx3cr1+/- mice.  
 
IL-17R effect on O3-induced pulmonary inflammation and injury   
 To further investigate the role of IL-17R in O3-induced pulmonary inflammation, 
we assessed BAL response phenotypes in Il17ra+/+ and Il17ra-/- mice.  Relative to 
respective air controls O3 significantly increased mean numbers of BAL macrophages (72 
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hr), PMNs (48 and 72 hr), epithelial cells (72 hr), and lymphocytes (72 hr) in Il17ra+/+ 
mice (Figure 2.6A).  O3 also significantly increased BAL macrophages (48 and 72 hr) 
and PMNs (72 hr), but not epithelial cells or lymphocytes in Il17ra-/- mice.  However, the 
number of O3-induced BAL macrophages (72 hr), PMNs (48 and 72 hr), epithelial cells 
(72 hr) and lymphocytes (72) were significantly greater in Il17ra+/+ mice compared to 
Il17ra-/- mice.   
 No significant differences in mean total BAL protein concentration were found 
between Il17ra+/+ and Il17ra-/- following air, or 48 hr O3 exposure (Figure 2.6B).  After 
72 hr O3, total BAL protein concentration was significantly attenuated in Il17ra-/- mice 
compared to Il17ra+/+ mice.  
 
Cx3cr1 and IL-17R deficiency on differential recruitment of cytokine IL-17A 
 Because IL-17R mRNA levels were elevated in Cx3cr1+/- mice following 48hr O3 
exposure, BAL IL-17A concentration was measured to determine if O3 exposure 
influences release of this proinflammatory cytokine.  Relative to air-exposed controls, 
mean concentration of IL-17A increased significantly after 24 and 48 hr O3 and returned 
toward basal levels after 72 hr.  Interestingly, IL-17A was not detected in Cx3cr1+/- mice 
at any time point.  Relative to air controls, 72 hr O3 also caused a significant increase in 
BAL IL-17A in Il17ra-/- mice (Figure 2.7B).  However, O3 had no significant effects on 
mean BAL IL-17A in Il17ra+/+ mice relative to genotype matched air controls (Figure 
2.7B).   
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Discussion 
The functional importance of CX3CR1 as a mediator of lung toxicity has been 
documented in previous human epidemiological studies.  Loss of function 
polymorphisms in CX3CR1 associated with reduced risk of respiratory ailments 
following chronic exposure to coal dust suggesting that CX3CR1 contributes to the 
disease pathogenesis (7).  The role of CX3CR1 in pulmonary injury resulting from shorter 
term, sub-acute exposures to environmental pollutants has not been investigated.  The 
present study was designed to investigate the role of Cx3cr1 in inflammation and injury 
induced by subacute exposure to O3, and the role of IL17 in this effect.  Deletion of either 
Cx3cr1 or IL-17R significantly diminished pulmonary inflammation and injury induced 
by O3 relative to wild type mice.  Furthermore, data from this study suggest that of the 
effect of CX3CR1 may be mediated through regulation of IL-17R. 
Previous studies have identified PMN infiltration into the airways as one of the 
primary indicators of O3-induced toxicity (21).  Following O3, an exposure-dependent 
increase of lavageable PMNs was found in both genotypes, but numbers of PMNs were 
significantly reduced in Cx3cr1-/- mice compared to Cx3cr1+/- mice.  Furthermore, BAL 
lymphocytes and macrophages (other cellular inflammatory phenotypes) were also 
increased by O3 and were significantly reduced in Cx3cr1-/- mice compared to Cx3cr1+/- 
mice.  It was also noted that there was a significant difference in pulmonary inflammation 
between genotypes following air exposure; suggesting that Cx3cr1+/- may be responding 
to air, and in the future all BAL phenotypes should be normalized to genotype-matched 
air controls in order to determine the effect of Cx3cr1 on O3-induced pulmonary 
inflammation.  Consistent with BAL inflammation, peribronchiolar inflammation, 
cellular proliferation and epithelial hyperplasia were also more prominent in Cx3cr1+/- 
mice compared to Cx3cr1-/- mice following O3 exposure.  This is the first study to 
identify the functional importance of Cx3cr1 in O3-induced lung disease.  Previous 
studies found that expression of CX3CR1 was associated with increased pulmonary 
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inflammation and pathological signs of disease in other disease models (12, 19, 22).  For 
example, significantly greater pulmonary inflammation was found in mice with BAL 
inflammatory cells expressing CX3CR1 following exposure to cigarette smoke; in 
particular, the macrophage inflammatory response was associated with CX3CR1 function 
(12).  Data reported previously suggests that deficiency CX3CR1 mitigates BAL protein 
concentration and immune cell migration to the lung following tuberculosis infection in 
humans (19).  Zhang et al. also found that CX3CR1 inactivation reduces RSV-induced 
pulmonary inflammation and pathology (22).  Findings from these investigations are 
consistent with BAL cell differentials and protein concentration in this study.   
Previous investigations suggest that expression of a number of proinflammatory 
cytokines (eg. MIP-2, IL-1β) are enhanced following a pulmonary insult, and are linked 
to PMN and macrophage recruitment (5, 6, 13, 23).  To determine whether deficiency of 
Cx3cr1 influences proinflammatory cytokine activity, and thus a potential mechanism 
through which Cx3cr1 modifies inflammation, MIP-2 and IL-1β expression was 
measured in lungs of O3-exposed Cx3cr1+/- and Cx3cr1-/- mice.  Interestingly MIP-2 
expression was greater in Cx3cr1+/- mice than Cx3cr1-/- mice after air exposure, 
suggesting that Cx3cr1 deficiency alters MIP-2 independent of O3 exposure.  O3 exposure 
also induced MIP-2, as well as IL-1, expression in both genotypes, but the increases 
found in Cx3cr1+/- mice were significantly greater than expression in Cx3cr1-/- mice.  
These results suggest that Cx3cr1 may modulate pulmonary inflammation through 
activation of MIP-2 and IL-1β.  While these findings are informative, further 
investigation is needed to determine the functional relationships between cytokines, 
Cx3cr1 and pulmonary inflammation. 
Because IL-17R is essential for lung neutrophil recruitment and lung expression 
of MIP-2 (16, 17), we hypothesized that Cx3cr1 regulates pulmonary inflammation and 
injury in response to O3 through upregulation of IL-17R (15, 17, 18, 24).  To initially test 
this hypothesis, we measured IL-17R expression in lung after O3 exposure in Cx3cr1+/- 
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and Cx3cr1-/- mice.  IL-17R expression correlated with the observed inflammatory 
response, and was elevated in Cx3cr1+/- mice after O3 exposure.  Moreover, IL-17R 
expression was significantly depressed in Cx3cr1-/- mice relative to wild-type mice.  
These results are consistent with a role for Cx3cr1 in regulation of the expression of IL-
17R in the lung.   
To further investigate the role of IL-17R in this model, we asked whether genetic 
deletion of Il17ra would attenuate the inflammatory response induced by O3.  Similar to 
our findings with Cx3cr1-/- mice, deficiency of Il17ra caused a significant reduction in the 
inflammatory response (BAL PMNs, macrophages, and lymphocytes) following O3 
relative to wild type mice, suggesting that IL-17R is involved in modulating the 
inflammatory cell recruitment into the lung.  This is consistent with findings of other 
studies that used Il17ra-/- mice to investigate mechanisms of pulmonary inflammation.  A 
recent study found that IL-17R was required for OVA allergen and viral-induced 
neutrophilia and general inflammation (18, 25, 26).  Wilson et al. also found that 
neutrophilia seen in the airways was associated with increased production of the 
chemokine CXCL5, which was found to be dependent on IL-17RA (18).  CXCL5 and 
CX3CL1 (fractalkine), the ligand for CX3CR1 are members of the same cytokine family, 
thus findings from previous studies (18, 26, 27) are consistent with the hypothesis that 
CX3CR1 initiates pulmonary inflammation via IL-17R activation.  
Interestingly IL-17A (cytokine) expression did not correlate with IL-17R 
activation.  Negligible levels of IL-17A were found in Cx3cr1+/- mice throughout the 
study, and IL-17A expression increased significantly in Cx3cr1-/- mice following O3 
exposure, and peaked following 48 hrs of O3 exposure.  Previous studies similarly found 
elevated IL-17A expression in IL-17R deficient mice (16).  Smith et al (16) suggested 
that there is a negative feedback loop where bound IL-17A prevents expansion of IL-17A 
-producing T-cells, therefore mice with functioning IL-17R will produce significantly 
less IL-17A than mice deficient for the receptor.  Real time PCR analysis suggested 
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activation of IL-17R is linked to Cx3cr1 function and this synergistic relationship may 
influence the inflammatory and injury response observed after O3.   
In summary our study found that, relative to wild-type mice, targeted deletion of 
Cx3cr1 enhanced the pulmonary inflammation and injury, proinflammatory mediator 
release, and IL-17R expression induced by O3.  Furthermore, Il17ra-/- mice were also 
protected against O3-induced inflammation and injury relative to wild-type mice.  Results 
therefore indicate that Cx3cr1 and Il17ra are important determinants of the pulmonary 
inflammatory response to O3 exposure.  Results also suggest a potential interaction 
between Cx3cr1 and Il17r, but further investigation is required to understand the 
mechanisms of this effect.  These novel findings provide insight to the mechanisms of 
pulmonary responses to environmental oxidant stimuli, and may lead to new intervention 
modalities. 
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Figure Legends 
 
Figure 2.1.  BAL inflammatory parameters in Cx3cr1+/- v. Cx3cr1-/- mice exposed to 
0.3 ppm O3.  Data are presented as means ± SEM (n=6-12 per group). +, significantly 
different from strain-matched air controls (p<0.05) *, significantly different from 
exposure-matched Cx3cr1+/-. 
 
Figure 2.2.  Cx3cr1 deficiency effects on O3-induced pulmonary pathology.  Paraffin-
embedded left-lung tissue sections were stained with H&E.  Representative light 
micrographs show less severe cellular proliferation in perivascular and peribronchiolar 
lesions and terminal bronchioles and neutrophilic infiltration from blood vessels to lung 
parenchyma in Cx3cr1-/- mice relative to Cx3cr1+/- mice exposed to O3.  av, alveoli; tb, 
terminal bronchioles; bv, blood vessels; br, bronchi.  Arrows indicate neutrophils 
infiltrating blood vessels.  Bars=100 µm. 
 
Figure 2.3.  Lung nuclear PCNA levels in Cx3cr1+/- and Cx3cr1-/- mice after O3.  
PCNA is a marker of lung injury and proliferation. (A) Representative western blots of 
PCNA expression.  (B) Immunostaining for PCNA in lung sections. 
 
Figure 2.4.  Affect of O3 exposure on chemokine expression in Cx3cr1+/- and Cx3cr1-/- 
mice.  (A)  BAL level of MIP-2.  (B)  Level of IL-1β found in BAL.  Data are presented 
as means ± SEM (n=6-12 per group). +, significantly different from strain-matched air 
controls (p<0.05) *, significantly different from exposure-matched Cx3cr1+/-. 
 
Figure 2.5.  Expression of IL-17R in Cx3cr1+/- and Cx3cr1-/- mice after O3 exposure.  
Fold change of IL-17R mRNA expression normalized to Cx3cr1+/- air control.  
Expression determined by qPCR. 
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Figure 2.6.  BAL inflammatory parameters in Il17ra+/+ v. Il17ra-/- mice exposed to 
0.3 ppm O3.  Data are presented as means ± SEM (n=6-12 per group).  +, significantly 
different from strain-matched air controls (p<0.05).  *, significantly different from 
exposure-matched Il17ra+/+ 
 
Figure 2.7.  Recruitment of cytokine IL-17A Cx3cr1+/- v. Cx3cr1-/- mice and Il17ra+/+ 
v. Il17ra-/- mice determined by ELISA.  Data are presented as means ± SEM (n=6-12 
per group).  +, significantly different from strain-matched air controls (p<0.05).  *, 
significantly different from exposure-matched Cx3cr1+/- or Il17ra+/+ 
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CHAPTER 3 
 
Cx3cr1 REGULATES PULMONARY INFLAMMATION FOLLOWING RSV 
INFECTION 
 58
Introduction  
 A previous study has determined that Cx3cr1 contributes to pulmonary 
inflammation and injury in the mouse following sub-acute O3 exposure (Chapter 2).  In 
humans, CX3CR1 has been linked to asthma, bronchiolitis and lung injury (1, 2).  
Clinical studies found that CX3CR1 activity and/ or expression was directly linked to 
RSV-induced bronchiolitis and inflammation (3-7).  Because Cx3cr1 contributes to 
pulmonary inflammation following exposure to the oxidant O3 (Chapter 2), and oxidant 
stress has been implicated as an important component to RSV infection and disease, it 
was hypothesized that Cx3cr1 is also important in the pulmonary response to RSV 
infection and RSV-induced pulmonary inflammation.  To test this hypothesis, wild type 
controls and mice with targeted deletion of Cx3cr1 (Cx3cr1-/-) were infected with RSV 
and vehicle controls.  Infection and RSV disease phenotypes were compared between the 
two groups.  Significantly reduced numbers of inflammatory polymorphonuclear 
leukocytes (PMNs) and macrophages in Cx3cr1-/- mice compared to wild type mice after 
RSV infection was consistent with a role for Cx3cr1 as an important determinant of 
susceptibility to RSV disease in mice.   
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Material and Methods 
 
Animal and Inhalation Exposure 
Age-matched (5-8 week), specific pathogen-free, inbred strain male C57BL/6JCx3cr1+/+ 
and C57BL/6JCx3cr1-/- mice were obtained from European Mouse Mutant Archive 
(EMMA) (Munich, Germany).  One group of mice from each strain was infected with 
1x106 plaque forming units (pfu) of RSV (RSV-19 provided by Dr. Fernando Polack) and 
sacrificed 1 day after infection, another group was sacrificed 5 days following infection, 
and vehicle control group was given Hep 2 cells in 50µL of HBSS and sacrificed after 5 
days.  Previous work from the laboratory has indicated that a minimum of 6 animals/ 
sample group were required for statistical evaluation.  A sample size of 6-8 was chosen to 
account for unplanned deaths during the study.  Mice were anesthetized with 100 mg/kg 
Nembutal (pentobarbital sodium), weighed, and the chest opened.  Lungs were lavaged in 
situ four times with Hanks' balanced salt solution (HBSS; 35 ml/kg, pH 7.2-7.4).  
Recovered BAL fluid was immediately cooled to 4°C and centrifuged.  The supernatant 
from the first lavage return was assayed for total protein (a marker of lung permeability) 
with the Bradford assay.  The four cell pellets were resuspended and pooled in 1 ml of 
HBSS, and the cells were counted with a hemacytometer.  An aliquot (10 µl) of BAL cell 
suspension was cytocentrifuged and stained with Wright-Giemsa stain (Diff-Quik, Baxter 
Scientific Products, McGaw Park, IL) for differential cell analysis.  Differential counts for 
epithelial cells (a marker of epithelial damage), neutrophils, lymphocytes, and 
macrophages (markers of inflammation) were done by identifying 300 cells according to 
standard cytological technique. 
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Results and Discussion 
 BAL PMN, macrophage, and lymphocyte concentrations were greatest 1 day after 
RSV infection and were significantly higher in Cx3cr1+/+ mice compared to Cx3cr1-/- 
mice.  In both genotypes BAL monocyte concentration was the greatest 5 days after RSV 
infection; however; no significant differences were found between genotypes.  These 
results were consistent with previous work that directly linked neutrophilia and 
lymphocyte recruitment to RSV infection (8-10).  Overall, BAL inflammatory cell 
concentration increased significantly following RSV infection in both genotypes, but was 
significantly greater in Cx3cr1+/+ mice compared to Cx3cr1-/- mice.  These findings 
suggest that Cx3cr1 contributes to pulmonary inflammation following RSV infection. 
However, the presence of inflammation in Cx3cr1-/- mice indicates that Cx3cr1 is not the 
sole regulator of the host’s response to RSV and other genes contribute to the observed 
response to RSV infection.   
The inflammatory response in both genotypes following RSV infection was 
similar to the response found in these mice after O3 exposure.  This may suggest that 
RSV and O3 induce pulmonary inflammation through similar mechanisms.  Previous 
results (Chapter 2) suggest that Cx3cr1 recruits IL-17R+ cells in the inflammatory 
process induced by O3.  Additional experiments are necessary to determine if the same 
mechanism(s) regulates response to RSV infection.   
Recent studies demonstrate that reactive oxygen species (ROS) production 
modulates RSV disease and O3–induced pulmonary injury, and genes that regulate ROS 
production may be responsible for O3 toxicity and RSV disease severity.  For example, 
Nrf2 (nuclear erythroid 2 p45-related factor 2) is a redox sensitive transcription factor 
that is essential in protection against oxidative lung injury resulting from O3 exposure 
(11) and RSV infection (12, 13)  Studies using Nrf2 wild-type and deficient mice found 
that inflammation was significantly attenuated in wild-type mice relative to Nrf2 deficient 
mice following O3 exposure or RSV infection, suggesting that the same mechanism is 
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responsible for both responses.  Similarly, data from this dissertation identifies Cx3cr1 as 
a candidate gene for both O3-induced and RSV-induced immune response.  Additional 
genes that regulate RSV-induced inflammation can be identified by either using this 
candidate gene approach, or through genome-wide haplotype association studies. 
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Figure Legend 
Figure 3.1.  BAL inflammatory parameters in Cx3cr1+/+ v. Cx3cr1-/- mice infected 
with RSV.  Data are presented as means ± SEM (n=6 per group). *, significantly 
different from strain matched air controls (p<0.05) +, significantly different from 
exposure-matched Cx3cr1+/+. 
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CHAPTER 4 
 
PHENOTYPIC CHARACTERIZATION OF PULMONARY RESPONSES TO 
RSV INFECTION ACROSS MULTIPLE INBRED STRAINS OF MICE
 67
Abstract 
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection 
(LRTI) in infants.  Approximately 70% of infants are infected with RSV within the first 
year of life.  Epidemiological studies show that individuals have varying responses to 
RSV infection, ranging from “cold-like” symptoms to death.   
Purpose:  The purpose of this research was to characterize the phenotypes of various 
inbred mouse strains following RSV infection, identify inbred strains that are 
differentially responsive to RSV infection, and evaluate heritability of RSV disease 
phenotypes. 
Methods:  Thirty-six inbred mouse strains (5-8 wk) were infected with a single dose of 
1x106 plaque forming units (pfu) of RSV (RSV-19) or control and sacrificed after 1 and 5 
days post-infection (pi).  To limit the number of confounding factors, only male mice 
were used in this study.  Pulmonary inflammation, changes in body weight, lung 
pathology, mucus cell metaplasia (MCM), and viral mRNA expression were analyzed 
and compared between and within all inbred strains of mice. 
Results:  No significant effects on inflammatory or other disease phenotypes were 
detected among strains treated with vehicle (control).  Statistically significant strain 
distribution patterns (SDPs) for protein, cellular, and MCM phenotypes in response to 
RSV infection were found among the inbred strains.  C3H/HeJ was the most resistant 
strain, and BALB/cByJ was among the most susceptible strains.  SDPs for the 
inflammatory phenotypes were largely concordant within 1 and 5 day post-infection 
sample times, but not between times.  The magnitude of RSV expression (viral load) did 
not correlate with disease severity across the strains.  Heritability estimates indicated that 
a significant portion of the variance in the RSV disease phenotype was attributed to 
genetic background. 
Conclusions:  Data from this study indicate differential strain-specific responses to RSV 
infection across multiple inbred strains.  Correlation analyses suggest that response to 
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RSV infection is regulated by different mechanisms 1 and 5 day(s) following infection.  
The data also indicate that viral expression was not related to RSV disease response.  
Furthermore, heritability estimates suggest that a significant portion of the phenotypic 
variation found between strains is due to genetic background, and provide the basis for 
future investigations to identify specific genes responsible for RSV disease phenotypes.   
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Introduction 
Respiratory syncytial virus (RSV) is the primary cause of hospitalization during 
the first year of life, and is the leading cause of bronchiolitis, pneumonia, mechanical 
ventilation and respiratory failure in infants worldwide (1).  RSV infection is also 
associated with the development of childhood asthma, and recurrent wheezing up to 7 
years old. In the United States alone, more than 100,000 infants are hospitalized with 
RSV-induced bronchiolitis each year (2).  RSV is highly virulent and only a small 
percentage of infections are completely asymptomatic.  While the majority of infected 
individuals present symptoms, the nature and severity of the symptoms vary among 
individuals.  For some infants infection induces cold-like symptoms, others require 
hospitalization and a small percentage of cases result in death.  The highest morbidity 
risk for RSV is among infants younger than 6 months (3, 4).  However, infants are not the 
only sub-population at risk to the effects of RSV.  The elderly and some adults are also at 
high risk for adverse effects of RSV disease (5).  The varying nature and severity of 
disease within a population suggest that host genotype regulates the phenotype (6-8).  
 Inbred strains have been used successfully to identify genetic factors that regulate 
susceptibility and response to pulmonary pathogens, inhaled particulates, and other 
environmental stressors (9-12).  A number of studies have reported mouse RSV 
phenotypes that resemble those found in humans (11).  Furthermore, studies using inbred 
mouse strains have found that response and susceptibility to RSV infection is influenced 
by genetic background (13, 14).  Prince et al (12) conducted an inbred strain screen on 20 
inbred mouse strains using viral titer as a marker of response to RSV infection.  The 
inbred strains formed a continuous strain distribution with P/N, C57L/N, and DBA/2N 
among the most susceptible and CBA/CaHN among the most resistant (13).  Stark et al 
(13) conducted a similar experiment and they found that C57/BL6J and A/J were the least 
susceptible strains and AKR/J was the most susceptible.  F1 progeny between C57/BL6J 
and AKR/J were relatively resistant to RSV infection suggesting that resistance to RSV 
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infection is a dominant trait.  However, when these mice were backcrossed to AKR/J the 
resulting progeny were unexpectedly highly susceptible to infection (14).  These findings 
suggest that susceptibility to RSV infection is a polygenic trait, but do not provide any 
insight into the genetics of RSV disease phenotypes and the host immune response.  The 
present investigation was designed to carefully characterize disease phenotypes of 
response to RSV infection across a panel of genetically diverse inbred strains of mice in 
order to: 1) model resistant and susceptible human disease phenotypes; 2) evaluate 
relatedness of disease phenotypes; and 3) estimate the genetic heritability of RSV disease 
phenotypes.  This study will also provide well-characterized phenotypes for haplotype 
association mapping of RSV disease quantitative trait loci (Chapter 5).    
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Material and Methods 
Animals and Infection  
Age-matched (5-8 week), specific pathogen-free, inbred strain male mice (Jackson 
Laboratory) were divided randomly into three groups per strain (Table 4.1).  One group 
of mice from each strain were infected with 1x106 plaque forming units (pfu) of RSV 
(RSV-19 provided by Dr. Fernando Polack) and sacrificed 1 day after infection, another 
group was sacrificed 5 days following infection, and vehicle control group was given Hep 
2 cells in 50µL of HBSS and sacrificed after 5 days.  Previous work from the laboratory 
has indicated that a minimum of 6 animals/sample group were required for statistical 
evaluation.  A sample size of 6-8 was chosen to account for unplanned deaths during the 
study.  Mice were anesthetized with 100 mg/kg Nembutal (pentobarbital sodium), 
weighed, and the chest opened.  Lungs were lavaged in situ four times with Hanks' 
balanced salt solution (HBSS; 35 ml/kg, pH 7.2-7.4).  Recovered BAL fluid was 
immediately cooled to 4°C and centrifuged.  The supernatant from the first lavage return 
was assayed for total protein (a marker of lung permeability) with the Bradford assay.  
The four cell pellets were resuspended and pooled in 1 ml of HBSS, and the cells were 
counted with a hemacytometer.  An aliquot (10 µl) of BAL cell suspension was 
cytocentrifuged and stained with Wright-Giemsa stain (Diff-Quik, Baxter Scientific 
Products, McGaw Park, IL) for differential cell analysis.  Differential counts for epithelial 
cells (a marker of epithelial damage), neutrophils, lymphocytes, and macrophages 
(markers of inflammation) were done by identifying 300 cells according to standard 
cytological technique. 
 
Lung Histopathology  
Left lung lobes were fixed with 10% neutral buffered zinc formalin for 24 hrs.  Proximal 
and distal intrapulmonary axial tissues were excised and embedded in paraffin and 
sectioned (5 µm).  Tissue sections were histochemically stained with hemotoxylin and 
 72
eosin (H&E) for comparison of pathology and injury between inbred strains.  The 
terminal bronchioles and alveoli were the primary focus of study because RSV infection 
causes inflammation and epithelial cell sloughing in these regions of the mouse lung.  
Tissue sections were stained via alcian blue-periodic acid shift (AB/PAS) double staining 
method for comparison of mucus cell metaplasia (MCM) between inbred strains. 
 
Mucus Cell Metaplasia  
Images of the histological sections were captured using a Axioskop 40 microscope, 
camera and the Axiovision software.  Black and white images, taken with a 10X 
objective lens, were analyzed with Scion image analysis software.  The mucus-containing 
area and the perimeter of the basal lamina from large airways, visually judged to be third 
generation bronchus, were used for the analysis.  The volume of mucus per airway was 
calculated using the following formula (15): 
 
SV = 4 / (BA) 
VS = VV / SV 
 
VV is the sum area of stained goblet cells, calculated during the Scion Image analysis.  
BA is the length of the basal lamina.  SV is surface area per unit volume and VS is 
volume per unit surface area of basal lamina (nanoliters/mm2).  VS values were 
calculated for each lung section and averaged for vehicle control and RSV infected 
groups within each strain.  Values for large airways were averaged for each treatment 
group, vehicle control or RSV infected within a strain.  Values are reported as the mean ± 
SEM for each strain where appropriate (n=3/infection/strain).  
 
Quantitative Real-time Polymerase Chain Reaction (qRT-PCR) 
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Total RNA was isolated from non-lavaged left lung pieces using an RNeasy Mini Kit 
(Qiagen, Valencia, CA) following the manufacturer’s procedure.  One g of total RNA 
was reverse transcribed into cDNA.  For quantitative PCR, an aliquot (1-2.5 l) of cDNA 
was amplified in a 25 l reaction containing 12.5 l 2X PowerSYBR Green Master Mix 
(Applied Biosystems, Foster City, CA) and 250 nM of each gene-specific forward and 
reverse primer by 10 minute hold at 95°C and 45 cycles at 95°C (15 seconds) -60°C (1 
minute) using the Applied Biosystems StepOne Plus Real-Time PCR Systems.  
Quantification of gene expression was determined by ΔCT values obtained by subtracting 
fluorescence detected number of cycles to threshold (CT) of 18s mRNA from those of 
target gene RNA in the same sample.   
 
Statistical Analysis 
Analyses of lavage and tissue parameters were analyzed by 3-way ANOVA (factors: 
exposure, time, strain) and comparisons of means followed Student-Newman- Keuls 
(SNK) a posteriori procedures.  It was previously determined that these parameters were 
distributed normally, but data were analyzed for homoscedasiticity before ANOVA 
analyses and transformed accordingly.  Particular attention was paid to compare duration 
of RSV infection to indicators of lung injury and inflammation.  Since percentages are 
not normally distributed, they were transformed (arcsine) and the transformed data for 
each variable was analyzed by two-way ANOVA (factors: time, strain).  Comparisons of 
the means followed SNK procedures.  The statistical significance in these and all other 
comparisons was accepted at p < 0.05.  Relatedness of RSV phenotypes was determined 
using Pearson and Spearman correlation coefficients (www.genenetwork.org). 
Heritability, or the fraction of the phenotype variability that is due to gene effects, 
was estimated by calculating the intraclass correlation and the coefficient of genetic 
determination, following the methods outlined by Festing (16).  Intraclass correlation, the 
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proportion of total phenotype variation due to between-strain differences or heritability in 
the broad sense, was calculated by the following formula: 
r1 =  (MSB - MSW) / [MSB + (n – 1)MSW] 
where rI is the intraclass correlation estimate, MSB is the mean square of the between-
strain comparison, MSW is the mean square of the within-strain comparison, and n is the 
number of animals tested per strain with corrections for differences in numbers of mice 
per strain. 
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Results 
 
Strain distribution patterns of RSV induced injury and airway inflammation  
Differences in BAL protein concentration were found between inbred strains 
among the vehicle control groups (Table 4.2).  Among the inbred strains studied 
129s1/SvlmJ and A/J were the most responsive (based on BAL phenotypes) to vehicle.  
Following RSV infection, lung protein concentration was the greatest in most inbred 
strains 5 days after RSV infection (Table 4.2), and the greatest percent increase in lung 
protein concentration (compared to respective vehicle controls) 5 days after infection was 
found in CAST/EiJ and WSB/WiJ mice (Table 4.2).   
Following infection with vehicle control the BAL inflammatory cell recruitment 
was minimal, but significant differences were found between inbred strains (Table 4.3).  
The most striking difference was noted for macrophage recruitment following vehicle 
control treatment.  Within this exposure group A/J and 129s1/SvlmJ were the most 
responsive.  Interestingly analysis of total cells in BALF after 1 day identified a 
continuous strain distribution pattern (Figure 4.1A).  This response was greatest in all 
strains 1 day after infection; and 5 days after infection the mean number of inflammatory 
cells in BAL was still significantly higher than strain-matched vehicle controls (Figure 
4.1B).  Mean BAL cell differentials 1 day after RSV infection ranged from 152.5 ± 4.4 
(WSB/WiJ) to 806.5 ± 53.7 (BALB/cJ).  Five days following infection cell differentials 
were significantly lower and ranged from 99.2 ± 2.7 to 482.7 ± 6.1.  The BALB/cByJ 
strain was one of the most responsive and C3H/HeJ was among the least responsive 
strains at both time points. 
Mean numbers of BAL PMNs were greatest 1 day after RSV in most strains 
ranging from 31.0 ± 0.3 (FVB/NJ) to 631.4 ± 5.4 (BALB/cByJ) (Figure 4.2A).  Mean 
numbers of PMNs 1 day post RSV in SM/J, C3H/HeOuJ, and MA/MyJ mice were 
significantly different from all the other strains.  BAL PMN numbers were significantly 
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lower after 5 days compared to 1 day and ranged from 0 (KK/HlJ) to 202.9 ± 1.9 
(PWD/PhJ).  Five days after infection mean PMN numbers from PWD/PhJ and SWR/J 
mice were significantly greater than all other strains.  Unlike PMNs, mean numbers of 
lymphocytes, macrophages and monocytes were highest 5 days after infection (Figure 4.3 
and Table 4.3).  After 5 days of infection, the greatest number of BAL lymphocytes was 
found in BTBRT mice (154.5 ± 4.4) and the fewest were found in SJL/J mice (0 ± 0).  
Lymphocyte numbers found in BAL of WSB/WiJ and BALB/cByJ mice were 
significantly different from other inbred strains.   
BAL epithelial cells were greatest 1 day after RSV infection, and BAL epithelial 
cell concentration was significantly higher in all strains 1 day after infection compared to 
vehicle controls and 5 day RSV infected mice (Table 4.3).  A continuous strain 
distribution pattern for mean numbers of BAL epithelial cells was found at 1 and 5 days 
post RSV infection, in which BALB/cByJ mice were consistently one of the highest 
responders and C3H/HeJ mice were one of the lowest responders.   
 
Pulmonary pathology 
No pulmonary histopathologic changes were noted in any strains of the vehicle 
exposed groups.  Qualitative histopathologic inspection of H&E stained lung sections 
indicated that lung pathology was most severe 1 day after infection in all inbred strains.  
In susceptible strains (e.g. A/J) the airway epithelium lining of the first daughter branch 
was partially exfoliated and severe inflammatory cell infiltration was marked in alveoli 
and proximal airways.  In resistant strains (e.g. C3H/HeJ) airway epithelium exfoliation 
was not found, however localized inflammatory cell infiltration was observed (Figure 
4.4).  After 5 days of infection, all lung pathology cleared in C3H/HeJ mice; however 
epithelial cell hyperplasia was still found in the airways of A/J mice (Figure 4.4). 
 
Mucus cell metaplasia (MCM) following RSV infection 
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Intraepithelial mucus was not detected in vehicle controls (data not shown). 
Among all strains examined after RSV infection, mean mucus concentration was greatest 
after 1 day of infection (Figure 4.5A) and declined 5 days after infection (Figure 4.5B).  
Quantitative analysis determined that one day following RSV infection, the greatest 
amount of intraepithelial mucus was found in SJL/J mice, and the lowest was found in 
BTBRT mice (Figure 4.5A and 4.5B).  Representative histology images indicated that 
intraepithelial mucus concentration is most prominent in the third generation bronchus of 
the airway (Figure 4.5C).  After 5 days of infection the highest bronchial mucus 
concentration was found in A/J and BALB/cByJ mice (Figure 4.5B).   
 
Viral expression 
An estimate of RSV infection in control and RSV-infected mice was obtained by 
measuring mRNA expression of the RSV-N gene.  RSV m-RNA expression directly 
reflects the amount of virus found in the lung (17).  RSV-N mRNA was not detected in 
any of the control groups.  Among the majority of infected strains, lung RSV viral 
mRNA expression was greatest 1 day following RSV infection, and 5 days after infection 
viral expression had significantly diminished, but the virus was still present (Table 4.4).  
One day post RSV infection, the greatest amount of RSV-N mRNA expression was found 
in AKR/J mice and the lowest mRNA expression was found in C57BL/6J mice (Table 
4.4).  In some strains, including DBA/2J and 129S1/SvlmJ, viral expression 5 days after 
infection was significantly higher than viral expression measured 1 day after RSV 
infection.  While viral expression in these few strains were the greatest 5 days post 
infection, detected viral expression was still significantly lower than those detected in 
AKR/J mice 1 day after RSV infection. 
 
Relatedness of RSV-induced phenotypes 
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BAL and histopathology data suggest that response to RSV infection was greatest 
1 day following infection compared to 5 days after infection.  Pearson and Spearman 
correlation analyses were performed to determine if the observed phenotypic responses 
were related to one another.  Rank analyses found that the phenotypic responses to RSV 1 
day after were almost completely independent of the observed responses 5 days following 
infection (Figure 4.6).  Interestingly, change in body weight 1 day after infection was 
significantly correlated with inflammatory responses found 5 days following infection.  A 
clinically important phenotype, MCM, was not correlated with other phenotypes (Figure 
4.6).  It was determined that viral mRNA expression 1 and 5 day(s) following infection 
were significantly correlated among the inbred strains of mice; however, viral mRNA 
expression was not related to any of the RSV disease phenotypes examined in this study 
(Figure 4.6).   
 
Heritability 
Heritability estimates were calculated for all the phenotypes to determine how 
much of the variance in the observed phenotypes is directly related to the genotype 
(between-strain variation) compared to environmental variance (with-strain variation).  
Heritability estimates for all the phenotypes in this study were greater than 35%, which is 
considered significant (18) (Table 4.5).  The highest degree of heritability was found for 
intraepithelial mucus concentration 1 and 5 days after infection, with estimates of 95.7% 
and 92.1% respectively (Table 4.5).  The lowest heritability was found for BAL epithelial 
cells 1 day following infection (44%).   
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Discussion 
One of the overall objectives of this study was to characterize RSV disease 
phenotypes in multiple inbred strains of mice in order to model resistant and susceptible 
human-like pathologies.  Multiple inflammatory and injury RSV disease phenotypes were 
characterized across 36 inbred strains, and significant inter-strain variation was found for 
each phenotype, and resembled differential disease severity found in humans (11).   
Pulmonary hyperpermeability was estimated by the total BAL protein 
concentration, and wild derived inbred strains such as CAST/EiJ and WSB/WiJ mice had 
significantly more BAL protein than any other inbred strains.  Interestingly, other 
markers of lung injury (e.g. histopatholgy and numbers of BAL epithelial cells) do not 
correlate with BAL protein in theses strains, and may suggest that different mechanisms 
are controlling these phenotypes in these strains.   
Inflammatory disease phenotypes across the strains suggest that C3H/HeJ mice 
are the least responsive to RSV infection and BALB/cByJ mice are among the most 
highly responsive to the virus.  BAL analysis determined that the inflammatory response 
found 1 day after infection was primarily driven by PMN infiltration.  This result was 
consistent with previous work that directly linked neutrophilia to RSV infection (19-22).  
However, the strain distribution patterns for some of the key inflammatory cell types (e.g. 
PMNs, lymphocytes) were not concordant at 1 and 5 days after infection.  This may 
suggest that inflammation does not peak at 1 day in all strains, and that the mechanisms 
regulating the kinetics of cellular inflammatory response to RSV differ between cell types.  
Although the strain distribution pattern was not identical for all phenotypes measured 
some strains were consistently more responsive, including BALB/cByJ, C3H/HeOuJ, and 
A/J.  C3H/HeJ, C57BL/6J and DBA/2J were among the least responsive to RSV infection.  
Interestingly, previous strain screens identified BALB/cByJ and C57BL/6J mice as 
highly susceptible and mildly susceptible, respectively, to RSV infection based on viral 
titers 4 days following infection (14, 23).   
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Of particular interest in the current study was the differential response of 
C3H/HeJ mice and C3H/HeOuJ mice.  C3H/HeJ and C3H/HeOuJ are genetically 
identical with the exception of a Tlr4 dominant negative mutation in C3H/HeJ (24).  
Results are therefore consistent with the hypothesis that the differential response to RSV 
observed in these two strains is in part due to a mutation in Tlr4 (24)  A recent study 
found that TLR4 contributes to RSV disease severity and TLR4 polymorphisms result in 
milder severity in humans (25).  The observed differential response between C3H/HeJ 
and C3H/HeOuJ mice in this study is consistent with other studies, and further SNP 
analysis found that the same Tlr4 polymorphisms found in C3H/HeJ mice were also 
present in C57BL/6J, AKR/J, DBA/2J and 129s1/SvlmJ mice, all of which were 
determined to be among the least responsive strains (Chapter 6).   
An unexpected observation in the inflammatory response was the complete 
absence of eosinophils across all strains.  Previous reports have emphasized the 
importance of eosinophilia in the murine inflammatory response to RSV (26, 27).  The 
absence of any eosinophils may be due to the strain of RSV (RSV-19 versus RSV-A2) 
used in this study, because different strains of RSV are known to elicit varying degrees of 
inflammation (28-32).   
 Stark et al. reported no variation in pulmonary pathology between inbred strains 
following RSV infection and Anh et al. reported that PMV (murine form of RSV) 
infection caused only subtle qualitative pathological effects (14, 33).  Both studies 
concluded that pathological responses resulting from RSV infection did not correlate with 
other measured phenotypes.  Results from the present study did not support those 
findings.  Analysis of histopathology sections revealed that all inbred strains exhibited 
some degree of pathological response (mild – severe) following infection, and the peak of 
this response occurred 1 day after infection.  Qualitative analysis of lung sections 
revealed pathological differences between inbred strains, and identified C3H/HeJ and 
C57BL/6J as the least responsive and A/J was noted to be the most responsive in terms of 
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pathology.  Interestingly Anh et al. found C3H/HeN and C57BL/6N to be two of the 
most responsive strains.  This discrepancy could be due to the source of the mice (mice 
used in this study were obtained from Jackson Laboratories, and mice used by Anh et al. 
were from Charles River Laboratories), or it may be due to the different phenotypes used 
to determine responsiveness; Anh et al. used viral titer, and this study used immune 
response to determine responsiveness (33).  However, the viral titers reported by Anh et 
al. correlated well with the viral mRNA findings in this study.  In both studies 
129S1/SvlmJ (129S1/SvlmN) were determined to be highly susceptible to infection, and 
SJL/J (SJL/N) were relatively resistant to RSV infection. 
Qualitative analysis of histopathology sections correlated with BAL inflammatory 
data, and future quantitative analysis of lung histopathology will be performed to 
determine the strength of this correlation.  While the histopathology findings in this study 
differed from those of Anh et al. the results were highly reproducible and little intrastrain 
variation was detected.  The main reason our histopathology conclusions varied from 
previous studies is likely due to the sample time for RSV-induced histpathological 
changes.  Earlier studies examined mice for pathological signs of pulmonary 
inflammation 4 and 5 days following infection respectively (14, 33); in the present study 
we noted that pathology severity peaked 1 day following infection and was largely 
cleared 5 days after infection.  It is possible that the lung pathology in the two previous 
studies was evident 1 day after infection and either cleared or was in clearing at the 
timepoint these groups examined the pathological effects of RSV infection. 
 In humans significant mucus cell metaplasia (MCM) is found in the airways of 
individuals suffering from RSV infection, is believed to be the main source of discomfort, 
and is thought to have a direct relationship to disease severity (34-36).  In the present 
investigation, MCM was measured in the epithelium of the main bronchus, and Pearson 
and Spearman rank coefficients indicated that MCM was not correlated with viral 
susceptibility or responsiveness to RSV.  Previously MCM in the mouse has been 
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associated with RSV infection and the resulting immune response using specific knock-
out mice, but no such correlation has been found across multiple inbred strains (37-40).  
The disparate responses found between human and mouse may occur because RSV is not 
native to mice, which is a criticism of this model (33, 41).  While no correlation with 
immune response or susceptibility was detected, significant inter-strain difference in the 
MCM phenotype were found.  Of the strains examined in this study SJL/J mice had the 
greatest mucus response, and BTBRT were the least responsive.  The response of SJL/J 
mice 1 day following RSV infection was significantly greater compared to the response 
of the other strains analyzed.  Based on the BAL cell data SJL/J mice do not have a 
profound inflammatory response to RSV.  This may suggest that MCM actually had a 
protective effect in SJL/J mice (42).  This same protective effect is not noted in any of the 
other inbred strains, which may indicate that this phenomenon is specific to the genotype 
of SJL/J mice.  Similar to other phenotypes examined in this study MCM had diminished 
significantly after 5 days, but still greater than MCM found in vehicle control mice. 
 Analysis of the relationship between all measured RSV disease phenotypes 
found that response 1 day following infection was generally unrelated to the response 
found 5 days following infection.  This observation suggests that different mechanisms 
regulate response to RSV at each timepoint.  BAL cell differentials indicate that the 
response found 1 day after infection is primarily driven by neutrophils.  We also found 
that BAL cell types associated with adaptive immunity were greatest 5 days after 
infection.  Interestingly Pearson correlation coefficients indicated that changes in body 
weight 1 day following infection was directly linked to the inflammatory response 5 days 
after infection.  Loss of body weight is an indicator of clinical illness, and a change in 
body weight 1 day after infection may be a predictor of the response 5 days following 
infection.  Data from a recent study suggest that some of the same genes that regulate 
RSV-induced pulmonary inflammation also influence the loss of body weight associated 
with RSV infection (43).  It is hypothesized that recruitment of chemokines and 
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inflammatory mediators following infection is responsible for the observed change in 
body weight. 
 Viral mRNA expression analyses confirmed that all inbred strains were 
successfully infected with RSV, and suggested that no strain was completely resistant to 
infection.  Although viral load was not definitively related to disease in this study, RSV 
viral load has been linked to disease severity noted mainly by weight loss and 
bronchiolitis in humans.  In particular, when RSV viral replication was reduced the 
inflammatory response and clinical signs of disease were significantly dampened (44-47).  
Contrary to results of previous studies, correlation analyses in the present investigation 
found that viral mRNA expression was not related to other disease phenotypes.  For 
example, based on all the phenotype data in this study BALB/cByJ were determined to be 
the most responsive strains to RSV infection, however measured viral load of this strain 
were one of the lowest.  This finding is in contrast to previous reports which found that 
BALB/cByJ mice are highly susceptible to infection and had the highest viral loads, but 
does support findings reported by Jafri and colleagues (13, 14, 48).  In humans, severity 
of RSV disease is measured by decrease lung function which usually results from 
pulmonary inflammation, and airway MCM.  Since viral load did not correlate with any 
disease phenotypes in the present study, identification of the genes that regulate viral load 
and replication will likely not be useful predictors RSV severity.  On the other hand, 
because BAL phenotypes were found to be relevant markers of disease, greater 
understanding of the genetics of RSV disease may provide great insight to the differential 
responses found in this study. 
 The results of this study indicate that susceptibility and response to RSV 
infection are complex traits.  Heritability calculations suggest that the observed 
variability of phenotypes between strains is largely attributed to the genetic differences 
between inbred strains, although environmental factors also contribute to the phenotypic 
variance.  Furthermore, the variation of response to RSV infection across inbred strains 
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approximates the wide variation in RSV disease found in humans, suggesting that 
identification of genetic determinants of RSV phenotypes in this model may be important 
for understanding human disease.  Results of this study provide the basis for future 
investigations to identify specific genes responsible for RSV disease phenotypes 
(Chapters 5 and 6). 
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Figure Legends 
 
Figure 4.1.  Total inflammatory cells measured in BAL following RSV infection.  
Total number of inflammatory cells in BAL from inbred strains of mice 1 day following 
RSV infection (A) and 5 days following infection (B).  Data are presented as mean ± 
SEM (n = 6-12 mice/group).  *Significantly different compared with lowest responder.  
+Significantly different compared with highest responder.  #Significantly different 
compared with all other strains, (P < 0.05).  
 
Figure 4.2.  Total PMNs measured in BAL following RSV infection.  Total number of 
PMNs found in BAL from inbred strains of mice 1 day following RSV infection (A) and 
5 days following infection (B).  Data are presented as mean ± SEM (n = 6-12 mice/group).  
*Significantly different compared with lowest responder.  +Significantly different 
compared with highest responder.  #Significantly different compared with all other 
strains, (P < 0.05). 
 
Figure 4.3.  Total lymphocytes measured in BAL following RSV infection.  Total 
number of lymphocytes found in BAL from inbred strains of mice 1 day following RSV 
infection (A) and 5 days following infection (B).  Data are presented as mean ± SEM (n = 
6-12 mice/group).  *Significantly different compared with lowest responder.  
+Significantly different compared with highest responder.  #Significantly different 
compared with all other strains, (P < 0.05). 
 
Figure 4.4.  Pulmonary pathology following RSV infection in inbred strains of mice.  
Representative images of lung sections from RSV-resistant C3H/HeH and RSV-
susceptible A/J inbred strains following vehicle and RSV infection.  Arrows indicate 
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areas of increased airway inflammation and bronchial epithelial proliferation 
(hyperplasia).  AV = Alveoli, BR = bronchus or bronchiole, BV = blood vessel.  Bar = 
100mm.  
 
Figure 4.5.  Pulmonary mucus cell metaplasia (MCM) in inbred strains of mice 
following RSV infection.  Quantitative analysis of intraepithelial MCM across inbred 
mouse strains 1 day following infection (A) and 5 days following infection (B). Data are 
presented as mean ± SEM (n = 3 mice/group).  *Significantly different compared with 
lowest responder.  +Significantly different compared with highest responder.  
#Significantly different compared with all other strains, (P < 0.05).  Representative 
images visualize AB/PAS-stained lung sections for intraepithelial mucous from two 
differentially responsive mouse inbred strains following vehicle and RSV infection (C).  
Arrows indicate intraepithelial mucous, which are stained blue.  AV = Alveoli, BR = 
bronchus or bronchiole, BV = blood vessel.  Bar = 100mm. 
 
Figure 4.6.  Node and edge representation of the relatedness of RSV response 
phenotypes in inbred strains of mice.  Pearson correlation coefficients noted on edges 
indicate the association between phenotypes.   
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Table 4.1.  Weight and age of inbred mouse strains. 
 
 
 
Inbred strains Approximate age (weeks) Weight (g) ± SEM 
A/J 7 22.3 ± 2.1 
AKR/J 6 24.8 ± 2.4 
BALB/cByJ 7 22.4 ± 1.9 
BALB/cJ 7 21.5 ± 1.4 
BTBRT 6 27.8 ± 3.2 
BUB/BnJ 7 - 8 26.2 ± 1.8 
CAST/EiJ 7 - 10 14.5 ± 1.6 
CBA/J 8 23.5 ± 2.9 
CE/J 8 21.5 ± 1.6 
C3H/HeJ 6 23.1 ± 2.5 
C3H/HeOuJ 6 – 8 21.8 ± 1.5 
C57BL/6J 6 21.3 ± 1.8 
DBA/2J 7 – 8 22.4 ± 2.1 
FVB/NJ 7 20.6 ± 2.5 
I/LnJ 6 – 7 23.6 ± 1.8 
KK/HlJ 6 – 8 31.8 ± 2.7 
LG/J 8 36.5 ± 2.2 
LP/J 6 15.8 ± 2.2 
MA/MyJ 6 24.6 ± 2.8 
MOLF/EiJ 7 - 9 12.2 ± 0.2 
MRL/MpJ 6 35.5 ± 3.3 
NOD/LtJ 6 – 7 21.5 ± 1.3 
NZB/BlNJ 7 25.2 ± 2.4 
NZW/LacJ 7 30.2 ± 2.7 
PL/J 6 24.2 ± 2.4 
P/J 6 23.5 ± 2.1 
PWD/PhJ 6 – 9 16.3 ± 2.3 
SJL/J 7 20.9 ± 1.1 
SM/J 6 24.6 ± 2.9 
SWR/J 6 19.4 ± 1.7 
WSB/WiJ 7 – 9 15.1 ± 2.1 
129s1/svlmJ 7 18.2 ± 1.8 
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Table 4.2.  Total protein concentration in BAL (g/ml) after vehicle (5 days) or RSV 
infection (1 and 5 days) in 31 inbred strains of mice.  Data are presented as mean ± SEM 
(n = 6-12 mice/group).   
 
 
Total BAL Protein 
Inbred Strains Vehicle 1 day RSV 5 day RSV 
A/J 120.9 ± 41.6 243.0 ± 49.8 231.2 ± 61.0 
AKR/J 289.8 ± 93.1 263.6 ± 49.2 392.5 ± 114.4 
BALB/cByJ 233.7 ± 17.7 359.3 ± 40.8 240.2 ± 19.2 
BALB/cJ 196.9 ± 21.5 425.1 ± 42.3 425.1 ± 59.8 
BTBRT 145.4 ± 8.3 258.0 ± 14.8 431.6 ± 59.8 
BUB/BnJ 301.5 ± 13.1 343.9 ± 50.4 364.8 ± 34.4 
CAST/EiJ 90.7 ± 15.1 212.4 ± 32.4 608.4 ± 100.4 
CBA/J 216.9 ± 34.0 233.7 ± 14.1 209.9 ± 19.0 
CE/J 54.5 ± 11.0 263.4 ± 73.2 189.1 ± 21.8 
C3H/HeJ 239.7 ± 20.3 150.7 ± 13.1 176.4 ± 12.1 
C3H/HeOuJ 223.6 ± 15.4 280.9 ± 95.4 319.8 ± 36.4 
C57BL/6J 362.2 ± 35.3 227.5 ± 23.9 227.9 ± 48.9 
DBA/2J 225.9 ± 45.4 313.4 ± 56.9 313.4 ± 80.5 
FVB/NJ 153.0 ± 7.0 320.0 ± 57.0 306.1 ± 65.8 
I/LnJ 242.4 ± 8.5 300.1 ± 26.1 307.5 ± 36.9 
KK/HlJ 204.3 ± 36.4 195.9 ± 28.9 200.8 ± 37.3 
LG/J 132.4 ± 19.5 125.6 ± 12.3 182.6 ± 23.1 
LP/J 110.1 ± 14.5 327.7 ± 45.6 277.2 ± 28.7 
MA/MyJ 127.0 ± 5.3 440.8 ± 57.7 245.5 ± 20.8 
MRL/MpJ 130.1 ± 6.8 223.6 ± 34.3 229.1 ± 22.9 
NOD/LtJ 173.2 ± 11.2 469.2 ± 27.8 168.5 ± 21.5 
NZB/BlNJ 160.5 ± 18.2 190.5 ± 28.9 165.5 ± 14.7 
NZW/LacJ 263.5 ± 21.6 214.1 ± 24.4 298.5 ± 32.3 
PL/J 146.5 ± 14.1 314.4 ± 38.8 348.4 ± 33.7 
P/J 56.3 ± 8.9 221.4 ± 28.9 181.6 ± 29.8 
PWD/PhJ 83.7 ± 18.3 321.2 ± 65.8 189.1 ± 29.6 
SJL/J 85.1 ± 12.2 141.4 ± 26.2 113.3 ± 22.2 
SM/J 117.8 ± 20.9 329.7 ± 47.1 133.3 ± 4.8 
SWR/J 80.0 ± 5.0 126.7 ± 21.6 108.6 ± 13.2 
WSB/WiJ 176.6 ± 17.5 220.4 ± 20.8 629.5 ± 49.5 
129s1/svlmJ 245.4 ± 33.2 258.6 ± 12.6 269.1 ± 30.2 
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Table 4.3.  BAL phenotypes following RSV infection.  Inflammatory cells recovered in 
bronchoalveolar lavage fluid (x103/ml) after vehicle (5 days) or RSV infection (1 and 5 
days) in 31 inbred strains of mice.  Data are presented as mean ± SEM (n = 6-12 
mice/group).   
 
 
 BAL Cell Differentials 
 Macrophages Monocytes Epithelial Cells 
Inbred Strains Vehicle 1 day 5 day Vehicle 1 day 5 day Vehicle 1 day 5 day 
A/J 192 ± 33.4 86.9 ± 8.4 205.7 ± 4.5 1.0 ± 0.3 24.8 ± 2.2 18.9 ± 1.5 23.5 ± 4.5  39.8 ± 2.2 30.5 ± 2.4 
AKR/J 48.6 ± 1.7  111.2 ± 4.7 44.2 ± 8.5 0.7 ± 0.2 7.2 ± 0.7  5.4 ± 2.0 8.0 ± 3.1 43.7 ± 3.3 32.1 ± 3.4 
BALB/cByJ 117.3 ± 4.8 57.0 ± 3.0 184.4 ± 3.6  2.1 ± 0.5 7.4 ± 0.7 26.8 ± 2.0 44.0 ± 4.8 57.0 ± 0.7 67.1 ± 1.6 
BALB/cJ 64.5 ± 3.7 99.8 ± 3.3 141.8 ± 5.7 2.6 ± 1.5 5.0 ± 0.3 53.0 ± 2.7 6.7 ± 2.5 56.0 ± 2.6 80.7 ± 4.7 
BTBRT 104.0 ±5.2 62.9 ± 6.1 153.2 ± 4.5 2.3 ± 0.4 5.9 ± 0.3 60.3 ± 3.2 13.3 ± 2.2 15.4 ± 0.3 36.2 ± 1.5 
BUB/BnJ 121.9 ± 2.4 79.0 ± 4.9 209.5 ± 1.7 1.2 ± 0.3 23.9 ± 2.9 18.8 ± 1.0 15.2 ± 1.3 73.4 ± 6.1 24.8 ± 0.5 
CAST/EiJ 78.8 ± 5.4 11.6 ± 1.5 111.1 ± 6.5 4.5 ± 1.0 3.9 ± 0.2 55.6 ± 5.7 15.7 ± 3.5 7.7 ± 1.9 12.8 ± 2.6 
CBA/J 78.5 ± 5.9 58.8 ± 7.1 208.8 ± 6.2 2.3 ± 1.5 11.7 ± 2.4 22.6 ± 2.9 30.8 ± 4.9 19.3 ± 1.1 35.9 ± 3.1 
CE/J 69.9 ± 2.9 79.2 ± 5.2  163.1 ± 4.2  0 0 0 16.8 ± 1.1 20.9 ± 1.4 44.2 ± 3.6 
C3H/HeJ 129.5 ± 2.5 103.2 ± 0.8 59.6 ± 6.9 0.6 ± 0.3 3.4 ± 0.7 7.1 ± 2.2 30.5 ± 2.1 35.2 ± 5.5 37.7 ± 4.2 
C3H/HeOuJ 103.8 ± 7.8 45.7 ± 0.3 169.6 ± 1.5 0.3 ± 0.2 1.8 ± 0.2 51.9 ± 1.6 25.2 ± 8.7 41.4 ± 0.8 76.9 ± 3.2 
C57BL/6J 45.6 ± 0.9 157.9 ± 6.2 76.1 ± 2.0 0.6 ± 0.7 1.3 ± 0.5  22.5 ± 3.6 7.6 ± 0.8 48.9 ± 3.5 39.3 ±3.6 
DBA/2J 136.5 ± 3.1 95.2 ± 6.1 61.8 ± 2.6 0.7 ± 0.3 8.9 ± 0.5 15.2 ± 1.3 25.8 ±2.9 59.1 ± 2.7 17.8 ± 1.5 
FVB/NJ 98.5 ± 1.9 68.8 ± 4.1 193.3 ± 1.3 0 7.7 ± 0.5 4.8 ± 0.6 9.4 ±  1.8 31.0 ± 0.3 28.9 ± 3.5 
I/LnJ 36.1 ± 0.4 29.8 ± 2.7 32.1 ± 8.7 3.4 ± 1.3 0.7 ± 0.1 3.2 ± 0.9 37.2 ± 0.4 17.9 ± 2.3 47.1 ± 2.6 
KK/HiJ 60.7 ± 3.1 100.7 ± 8.9 282.8 ± 2.5 0 2.5 ± 0.3 15.7 ± 2.4 46.4 ± 1.8 66.4 ± 4.5 70.7 ± 5.6 
LG/J 61.3 ± 2.5 122.7 ± 10 124.8 ± 15 0 0.9 ± 0.2 6.1 ± 1.0 10.3 ± 1.4 15.9 ± 4.2 60.1 ± 9.0 
LP/J 83.8 ± 1.2 57.5 ± 1.5 103.3 ± 4.3 3.7 ± 1.7 2.3 ± 0.5 13.2 ± 1.7 36.9 ± 5.2 25.3 ± 1.5 106 ± 4.6 
MRL/MpJ 90.5 ± 2.6 59.3 ± 2.7 69.7 ± 5.3 0 0.8 ± 0.2 7.5 ± 0.9 22.8 ± 2.0 21.8 ± 0.9 51.4 ± 1.6 
NOD/LtJ 122.8 ± 6.1 55.2 ± 6.3 171.1 ± 4.9 3.4 ± 0.9 8.9 ± 2.1 18.0 ± 2.2 23.7 ± 3.7 21.4 ± 1.4 65.1 ± 3.6 
NZW/LacJ 142.5 ± 1.4  84.5 ± 5.8 106.1 ± 1.5 0.4 ± 0.2 0.5 ± 0.1 19.7 ± 2.8 19.6 ± 1.4 22.7 ± 1.7 54.2 ± 2.5 
PL/J 24.6 ± 0.2 24.6 ± 0.2 101.6 ± 2.0 0 0 25.4 ± 2.0 27.1 ± 3.4 21.9 ± 2.3 33.4 ± 0.2 
PWD/PhJ 94.7 ± 8.7 10.9 ± 2.9 69.3 ± 1.3 0.6 ± 0.2 35.9 ± 3.5 19.2 ± 1.4 15.5 ± 1.4 4.6 ± 0.1 20.5 ± 1.1 
SJL/J 95.0 ± 0.7 86.4 ± 12.1 66.8 ± 3.5 0.2 ± 0.1 0.8 ± 0.1 10.2 ± 1.3  11.1 ± 0.5 28.1 ±  2.7 14.6 ± 2.1 
SWR/J 89.4 ± 1.7 135.6 ± 16 132.0 ± 8.4 0 8.2 ± 0.5 9.8 ± 0.8 20.9 ± 2.0 24.7 ± 2.9 17.8 ± 1.6 
WSB/WiJ 80.1 ± 1.4 25.9 ±  2.7 126.8 ± 1.1 15 ± 0.7 3.0 ± 0.8 71.6 ± 0.8 37.0 ± 0.5 10.6 ± 0.2 63.4 ± 1.4 
129s1/svlmJ 270.3 ± 2.0 158.0 ± 2.5 54.4 ± 5.6 3.1 ± 0.5 8.6 ± 1.1 5.2 ± 1.9 28.5 ± 2.1 41.1 ± 2.6 25.9 ± 6.1 
 
 
 
 
 
 
 102
Table 4.4.  RSV-N mRNA expression following infection.  RSV-N mRNA expression 
normalized to 18S mRNA expression in 32 inbred strains of mice.  Data are presented as 
mean ± SEM (n = 6-12 mice/group).   
 
 
RSV-N mRNA Expression 
Inbred Strains Vehicle 1 day RSV 5 day RSV 
A/J 0 1.0 ± 0.3 0.9 ± 0.2 
AKR/J 0 5.8 ± 2.1 6.1 ± 0.7 
BALB/cByJ 0 6.0 ± 1.1 4 ± 0.6 
BALB/cJ 0 6.1 ± 1.1 4.5 ± 0.6 
BTBRT 0 4.2 ± 1.0 4.3 ± 0.8 
BUB/BnJ 0 1.4 ± 0.6 1.1 ± 0.2 
CAST/EiJ 0 0.9 ± 0.2 0.8 ± 0.4 
CBA/J 0 4.2 ± 1.0 2.5 ± 0.8 
CE/J 0 1.1 ± 0.5 2.1 ± 0.9 
C3H/HeJ 0 1.3 ± 0.6 1.1 ± 0.5 
C3H/HeOuJ 0 5.4 ± 1.2 3.3 ± 0.9 
C57BL/6J 0 2.7 ± 0.8 2.5 ± 0.9 
DBA/2J 0 4.3 ± 1.1 6.2 ± 1.2 
FVB/NJ 0 6.1 ± 2.0 2.2 ± 0.7 
I/LnJ 0 2.6 ± 1.3 1.4 ± 0.7 
KK/HlJ 0 5.5 ± 1.9 4.1 ± 2.3 
LG/J 0 3.3 ± 1.4 2.9 ± 1.1 
LP/J 0 0.9 ± 0.3 1.3 ± 0.2 
MA/MyJ 0 3.9 ± 1.0 3.2 ± 0.6 
MOLF/EiJ 0 2.2 ± 0.4 1.7 ± 0.2 
MRL/MpJ 0 1.5 ± 0.4 1.2 ± 0.3 
NOD/LtJ 0 7.1 ± 1.4 5.1 ± 0.2 
NZB/BlNJ 0 5.1 ± 1.5 4.7 ± 2.1 
NZW/LacJ 0 5.5 ± 2.5 4.3 ± 0.7 
PL/J 0 2.6 ± 0.3 1.9 ± 0.5 
P/J 0 3.3 ± 1.1 3.9 ± 0.8 
PWD/PhJ 0 2.3 ± 0.9 2.6 ± 0.7 
SJL/J 0 7.5 ± 2.6 2.6 ± 1.0 
SM/J 0 4.3 ± 1.1 2.1 ± 0.6 
SWR/J 0 5.3 ± 1.4 1.1 ± 0.3 
WSB/WiJ 0 2.5 ± 0.9 2.6 ± 0.7 
129s1/svlmJ 0 3.0 ± 1.6 7.9 ± 1.1 
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Table 4.5.  Heritability of phenotypes.  Estimated heritability of RSV phenotypes 
among 33 inbred strains of mice.  Inflammatory cells differentials were measured in BAL, 
Intraepithelial mucus was determined from AB/PAS stained light micrographs and viral 
load was measured using right lung mRNA. 
 
 
Heritability of Phenotypes 
 1 day after infection 5 days after infection 
Lung Hyperpermeability 47.6% 55.8% 
Total cells in BALF 72.1% 74.8% 
Epithelial Cells 44.0% 64.6% 
Lymphocytes 63.1% 68.0% 
Macrophages 55.8% 68.0% 
Monocytes 63.1% 61.7% 
Neutrophils 65.0% 89.8% 
Intraepithelial Mucus 95.7% 92.1% 
Viral load 78.5% 72.6% 
 
 
 
CHAPTER 5 
 
GENETIC CONTRIBUTION TO RSV RESPONSE AND SUSCEPTIBILITY 
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Abstract 
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection 
(LRTI) in infants.  Approximately 70% of infants are infected with RSV within the first 
year of life.  Previous in vivo studies have suggested that RSV susceptibility is a 
polygenic trait; however, the specific genes regulating this phenotype have yet to be 
identified.   
Purpose:  The overall objective of this research was to utilize haplotype association 
approaches to identify quantitative trait loci (QTL) that contain genes that contribute to 
differential disease phenotypes in response to RSV infection among multiple inbred 
strains of mice. 
Methods:  BAL and pathology phenotypes following vehicle and RSV infection were 
measured across 36 inbred mouse strains.  Using haplotype association mapping, the 
degree of correlation between the observed phenotypic differences and the genotype of 
36 inbred strains was used to determine candidate quantitative trait loci (QTLs).  
Candidate genes were identified within the most prominent QTLs based on biological 
plausibility (i.e. potential role in the phenotype based on published literature).  Statistical 
analysis was performed to determine the relationship between genetic SNPs and RSV 
disease.  SNPs with p<0.05 were considered important to RSV-induced immune 
response. 
Results:  A previous study (Chapter 4) found a continuous strain distribution pattern of 
phenotypes in response to RSV infection across inbred mouse strains, and indentified 
highly responsive (e.g. BALB/cByJ, C3H/HeOuJ) and low responsive (C57BL/6J, 
C3H/HeJ) mouse strains.  Data from this same study suggest that response to RSV 
infection is a polygenic trait.  In the present study, haplotype association analyses 
identified eleven QTLs that were associated with RSV inflammation, and 9 candidate 
genes were identified within these QTLs.  SNPs within St18, Marco, Stat4, Kif27, 
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Slc28a3 and Mpg were significantly associated with RSV disease phenotypes, suggesting 
a potential role in regulating the immune response to RSV infection. 
Conclusions:  Haplotype association mapping identified a number of QTLs that partially 
accounted for genetic variance in important RSV disease phenotypes.  Further, candidate 
genes were identified that have biological plausibility and functional polymorphisms 
correlated with RSV responses among the inbred strains.  These findings add to our 
understanding of RSV-induced immune responses, and may lead to novel intervention 
strategies to prevent disease progression.  
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Introduction 
Respiratory syncytial virus (RSV) is the primary cause for hospitalization during 
the first year of life, and is the leading cause of bronchiolitis, pneumonia, mechanical 
ventilation and respiratory failure in infants worldwide (1).  RSV is also a significant 
cause of respiratory illness in immunocompromised adults and the elderly (2).  While the 
majority of infected individuals present symptoms, the nature and severity of the 
symptoms vary among individuals (3, 4).  For some, infection induces cold-like 
symptoms, others require hospitalization, and a small percentage of cases result in death.  
The wide variation in response to RSV infection suggests that susceptibility and response 
to RSV is influenced by the genotype of the host (1, 5, 6).   
Previous in vivo studies have found that susceptibility and response to RSV 
infection is a multigenic trait, but did not determine the genes responsible for 
susceptibility and response (5, 6).  Other studies found that transcription factors including 
NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) and c/EBP 
(CCAAT-enhancer-binding proteins) regulate susceptibility to infection, and 
inflammatory and viral response mediators such as TLR4 (toll-like receptor 4), CX3CR1 
(chemokine (C-X3-C motif) receptor 1), MX1 (myxovirus resistance 1) and STAT (signal 
transducer and activator of transcription) may modulate the response to infection (7-10).  
Nearly all components of the immune system have been implicated in the pathogenesis of 
RSV infection, including inflammatory cells and their products such as chemokines, 
cytokines, and soluble inflammatory mediators (11-15).  Epidemiology studies in 
children suggest that polymorphisms in surfactant association proteins and several 
cytokines are associated with the immune response to RSV (16-24).  Currently there is 
controversy surrounding the role all of these components play in the pathogenesis of RSV 
infection.  A number of animal and epidemiological studies have sought to identify the 
genes that regulate RSV disease; however, the exact genes responsible for susceptibility 
and response to RSV infection have yet to be identified.   
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 Severity of RSV infection is a complex, multigenic trait, which is characterized 
by many phenotypes.  Several genes have previously been linked to certain RSV 
phenotypes using a candidate gene approach; however, the genetic profile responsible for 
the disease as a whole is still unknown.  In the present study, haplotype association 
analyses were used to identify QTLs and candidate genes that account for genetic 
variations in RSV disease severity among inbred strains of mice.    
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Material and Methods 
Animals and Treatment 
Thirty-six male inbred strains of mice were studied (Table 3-1).  All mice were 
approximately 6-10 weeks of age, and purchased from Jackson Laboratory (Bar Harbor, 
ME).  Marco deficient mice (Marco-/-) were developed using homologous recombination 
and were backcrossed for at least 8 generations to the BALB/cByJ background (provided 
by T. Kodama, University of Tokyo, Tokyo, Japan).  All mice were individually housed 
and handled as described in Howden et. al (25).  Mice were infected with 106 plaque-
forming units (PFU) of human RSV-19 strain in 50 μL Hank’s balanced salt solution 
(HBSS) by intranasal instillation.  HBSS containing Hep-2 cell lysates were intranasally 
instilled into mice for vehicle controls.  Animals were killed 1 or 5 days after intranasal 
instillation (n = 6 per group).  On designated post-instillation days, mice were killed by 
sodium pentobarbital overdose (104 mg/kg body weight).  All animal use was approved 
by the National Institute of Environmental Health Sciences and Animal Care Use 
Committee. 
 
Haplotype Association Mapping 
Haplotype association mapping was performed as previously described (26, 27).  
Haplotype associations were calculated using a modified F-statistic based on genotype-
phenotype pairings at each 3-SNP window across a 650,000 SNP data set.  SpotFire 
(SpotFire, Inc.) was used to plot LogP values across the mouse genome.  Genes within 
the most prominent QTLs (those with LogP values >4) were identified using SpotFire 
and their functions were assessed using BioGPS (www.biogps.gnf.org).  SNPs of 
candidate genes were identified and analyzed using The Jackson Laboratory Mouse 
Phenome Database (www.phenome.jax.org). 
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Lung Bronchoalveolar Lavage Fluid (BALF) and Cell Preparation 
Mice were euthanized with sodium pentobarbital (104 mg/kg) 1 or 5 days following 
vehicle or RSV infection, and BAL was performed and cell differentials were determined 
as previously described (28).  The time points chosen for evaluation of inflammation and 
injury were based on previous investigations that characterized the kinetics of 
inflammation and injury responses to RSV infection (see Chapter 4).   
 
Lung Histopathology.   
Left lung lobes were fixed with 10% neutral buffered zinc formalin for 24 hrs.  Proximal 
and distal intrapulmonary axial tissues were excised and embedded in paraffin and 
sectioned (5 µm).  Tissue sections were histochemically stained with hemotoxylin and 
eosin (H&E) for comparison of pathology and injury between inbred strains.  The 
terminal bronchioles and alveoli were the primary focus of study because RSV infection 
causes inflammation in epithelial cell sloughing in these regions of the mouse lung.  
Tissue sections were stained via alcian blue-periodic acid shift (AB/PAS) double staining 
method for comparison of mucus cell metaplasia (MCM) between inbred strains. 
 
Statistical Analysis 
The statistical association between genotype and phenotype within mouse strains was 
calculated using the two-tailed Student’s t-test.  The statistical significance in these 
comparisons was accepted at p < 0.05.  Only the significance of nonsynonymous coding 
SNPs were used in this study, if more than one nonsynonymous coding SNP was found 
within a gene multiple comparisons were performed.  
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Results 
Phenotypic characterization of RSV disease across inbred mouse strains 
 Thirty-six inbred mouse strains were previously infected with vehicle control or 
RSV and BAL and pathology phenotypes were measured 1 and 5 day(s) following 
infection (Chapter 4).  Data from this study indicated that the total cell and PMN 
responses to RSV infection are greatest 1 day after infection, and the lymphocyte and 
monocyte responses were greatest 5 days after infection (Figures 4.1).  A continuous 
strain distribution pattern was found for all of the phenotypes analyzed and certain strains 
were determined to be highly responsive to RSV infection, and others were found to be 
relatively non-responsive to infection.  For example BALB/cByJ was one of the most 
responsive strains and C3H/HeJ was among the least responsive strains (Table 4.3).  The 
observed continuous strains distribution pattern (Figures 4.1, 4.2, 4.3), limited intrastrain 
variation (Table 4.3) and high heritability estimates (Table 4.5) indicate that response to 
RSV infection is a multigenic trait. 
 
Identification of candidate genes for susceptibility and response to RSV infection 
Haplotype association was utilized to perform genome-wide searches for QTLs 
for four BAL phenotypes (total inflammatory cells and PMNs 1 day RSV infection, 
lymphocytes and monocytes 5 days following infection) using the entire inbred strain 
data set (Table 4.3).  Haplotype association mapping identified QTLs that exceeded LogP 
= 4 for the total cellular inflammatory response located on chromosomes 1, 10, and 12 
(Figure 5.1A).  QTLs on chromosomes 10 and 13 were linked to the PMN response 
(Figure 5.1B).  Haplotype association mapping for monocyte response identified QTLs 
on chromosomes 1, 14 and 15 (Figure 5.1C).  Linkage analysis for BAL lymphocyte 
responses identified QTLs located on chromosomes 1, 4, 11 and 13 (Figure 5.1D).  
Further examination of these QTLs identified genes that have a strong association with 
particular RSV phenotype (Figure 5.2).   
 112
 
Identification of candidate susceptibility genes 
The aforementioned QTLs contained many genes; however several of these genes 
that could be reasonably linked to RSV-induced inflammation and lung injury were 
identified and considered to be candidate genes (i.e. they have biological plausibility 
based on published studies about their effects).  Included among these gene candidates 
are St18, Tbk1, Marco, Fndc3a, Stat4, Stat1, Spnb2, Il9r, Slc28a3, Mpg and Kif27 
(Tables 4.1 and 4.2).  Nonsynonymous coding SNPs of these candidate genes were 
identified using The Jackson Laboratory Mouse Phenome Database across inbred mouse 
strains used in this study and statistical analysis revealed that several of the SNPs 
identified were significantly associated with the immune response to RSV infection 
(Table 5.2).  Figure 5.3 illustrates the effect of these significant SNPs on RSV disease 
phenotypes.  For example, St18 contains a Thr961Ser mutation that was associated with 
RSV-induced increase of BAL total inflammatory cells across all of the strains 
(p<0.0001) (Table 4.1).  An Asp392Val mutation in Marco on chromosome 1 
significantly correlated with BAL monocyte concentration 5 days after infection 
(p<0.0001).  Stat4, Slc28a3, Mpg, and Kif27 contain SNPs that resulted in amino acid 
mutations (Table 4.3) and were significantly associated with BAL lymphocytes after 5 
days RSV infection (p<0.05).  Statistical analysis was not performed using Stat1 and Il9r 
because no nonsynonymous coding SNPs were found within these genes.  
 
Genetic deletion of Marco modifies RSV-induced pulmonary inflammatory response and 
injury 
 The role of Marco on RSV-induced pulmonary inflammation was further 
examined by infecting Marco+/+ and Marco-/- mice with vehicle control or RSV for 1 or 5 
days.  Genotype specific differences were found in vehicle control groups, in which a 
significantly greater BAL protein concentration was found in Marco+/+ mice compared to 
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Marco-/- mice (Figure 5.4).  Relative to respective vehicle controls RSV infection caused 
a significant increase of BAL protein concentration in Marco-/- mice; however infection 
did not affect BAL protein concentration in Marco+/+ mice.  No significant differences in 
BAL monocytes, lymphocytes, and macrophages were found between genotypes 
following vehicle treatment; however, Marco+/+ mice had significantly greater BAL 
polymorphonuclear leukocytes (PMNs) after vehicle treatment compared to Marco-/- 
mice.  Relative to respective vehicle treated mice, 1 and 5 days of RSV infection caused 
significant increases mean numbers of all BAL inflammatory cells.  Numbers of all cell 
types were significantly higher in Marco-/- mice compared to Marco+/+ mice (Figure 5.5). 
 H&E stained lung section from Marco+/+ and Marco-/- vehicle treated mice were 
normal and showed no signs of disease.  Indication of neither pulmonary injury nor 
inflammatory cell response was found in either genotype after 1 day of RSV infection.  
However, significant peribronchiolar inflammation, cellular proliferation, and epithelial 
hyperplasia were found in the terminal bronchioles of both genotypes following 5 days of 
RSV infection.  Peribronchiolar inflammation observed in Marco-/- mice was greater than 
the response found in Marco+/+ mice; which supported BAL protein and inflammatory 
cell data following RSV infection.  Yet, cellular proliferation and epithelial hyperplasia 
was greater in Marco+/+- mice (Figure 5.6). 
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Discussion 
 Considerable evidence has suggested that genetic background is an important 
determinant of RSV disease severity, but the identity of susceptibility genes remains 
unclear.  To determine the within-strain variation in RSV disease phenotypes, we 
phenotyped 36 inbred mouse strains following infection with vehicle and RSV (Chapter 
4).  Results of that study suggested that response to infection is a multigenic trait.  To 
dissect the specific chromosomal regions responsible for the phenotypic variation 
between inbred strains, genomewide haplotype association mapping analysis was 
performed for BAL inflammatory cell phenotypes, and numerous QTLs were found for 
all of these phenotypes.  QTL identification was based solely on haplotype association 
mapping, but candidate genes were selected according to prior knowledge of the function 
of a gene.  Several well characterized genes known to be essential for viral response, 
pulmonary inflammation, and cytokine trafficking were found within the identified 
QTLs.  Some of the genes strongly associated with the measured phenotypes are poorly 
characterized and little is known about their function.  Statistical analysis found that 
SNPs within these genes significantly enhanced or reduced the response to infection 
among inbred strains, and suggested they are important targets for future investigation of 
their roles in RSV disease progression. 
Haplotype association mapping was performed for BAL total inflammatory cells 
and PMNs (1 day after RSV infection), and lymphocytes and monocytes (5 days 
following infection) to identify QTLs within the mouse genome associated with these 
phenotypes.  Haplotype association mapping of total lavageable cells identified 3 QTLs 
(LogP values greater than 4) on chromosomes 1, 10 and 12.  Several QTLs with LogP 
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values between 3.5 and 4 (chromosomes 1, 3 and 5) were also identified.  Query of the 
QTLs on chromosomes 1, 10, and 12 identified a number of candidate genes based on 
biological plausibility.  Within the chromosome 10 QTL is St18, a transcription factor 
that regulates expression of proinflammatory genes such as IL-6, IL-1α, and TNF-α in 
human fibroblast (29).  Possible functional SNPs within this candidate gene were 
identified using The Jackson Laboratory Mouse Genome Informatics (MGI) website 
(www.informatics.jax.org).  Interestingly, inbred strains of mice that are homozygous for 
functional mutations in St18 (Thr961Ser) had significantly greater numbers of BAL 
lymphocytes after RSV infection compared to inbred strains that were wild type for the 
mutations.  These results are consistent with a functional role of St18 in RSV disease, and 
understanding the mechanisms of St18 activity in response to RSV should provide novel 
insight to susceptibility.   
The QTL associated with BAL monocytes on chromosome 1 contained Marco.  
Previous studies suggest that Marco has protective effects in the lung following 
inhalation of particulate matter, and bacterial infection (30-33).  Infection with RSV leads 
to oxidative stress, which contributes to alveolar epithelial cell injury, and pulmonary 
inflammation (34-36).  Oxidative stress phenotypes are regulated by various genes, one 
of which is Marco (37, 38).  Recent studies found that Marco expression reduces 
pulmonary injury and inflammation (31).  Because Marco modulates oxidative stress-
induced lung injury, and haplotype association mapping linked Marco genotype to BAL 
monocyte migration, it was hypothesized that Marco provides protection against RSV-
induced pulmonary inflammation, especially monocyte response.  Following RSV 
infection, an infection-dependent increase in lavageable monocytes was found in both 
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genotypes, but numbers of monocytes were significantly reduced in Marco+/+ mice 
compared to Marco-/- mice.  Consistent with BAL data, peribronchiolar inflammation, 
and cellular inflammation were more prominent in Marco-/- mice relative to Marco+/+ 
mice following RSV infection.  The role of Marco in reducing neutrophilia is well 
documented (30, 31, 37), and is supported by this study.  However, little is known about 
how Marco regulates monocyte migration, but the data from this investigation suggest 
that Marco may be an important regulatory component of this RSV disease phenotype.   
Stat1 and Stat4 on chromosome 1 are candidate genes that were identified through 
haplotype association mapping for BAL lymphocytes 5 days after RSV.  RSV vaccine-
enhanced disease is dependent on Stat4 expression, and Stat4 is believed to modulate 
RSV-induced inflammation through activation of IL-12, and other studies have found that 
RSV activates STAT signaling in human epithelial cells (10, 39).  Computational 
analyses identified a functional mutation (Thr709Met), and strains of mice with this 
mutation had significantly enhanced BAL lymphocyte recruitment relative to strains that 
have the wildtype Stat4 genotype.  Results suggest that this polymorphism is a gain of 
function mutation, but further investigation is necessary to gain molecular insight.  Stat1 
has very different functions from those of Stat4; however, SNP data for Stat1 were 
unavailable for analysis. 
Another lymphocyte QTL was found on chromosome 11, and Slc28a3 was 
identified as a candidate gene within this QTL.  Genetic variants of Slc28a3 are 
associated with the immune response in chronic lymphocytic leukemia (CLL) patients.  
The immune response in patients with polymorphisms of this gene was significantly 
reduced compare to individuals without these polymorphisms, suggesting that mutations 
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to Slc28a3 result in loss of function (40).  Similarly, in the present study a reduced 
lymphocyte response to RSV was found in strains with the Slc28a3 Asn697Asp mutation 
compared to strains without the mutation. 
Kif27 is highly expressed in ciliated cells and extremely important to cilia 
function.  Without full function of Kif27 lung cilia cannot clear mucus and other foreign 
particles from the lung (41).  Cilia dysfunction such as ciliostasis, clumping, or loss of 
cilia is responsible for some phenotypes of RSV disease (42).  Two nonsynonymous 
coding SNPs within Kif27 were identified, and lymphocyte migration was significantly 
higher in inbred strains of mice with either of the SNPs relative to strains with wild type 
Kif27.  Because of the previous association of Kif27 with RSV disease in humans (43), 
this candidate gene is particularly interesting for additional investigation into its 
functional role in differential response to RSV in the mouse model.  
Data for nonsynonymous coding SNPs were not available for Il9r.  However, it 
may be hypothesized to play a role in regulating inflammation following RSV infection.  
Numerous studies have found that Il9r is responsible for asthma and general allergic 
airway inflammation (31, 43-45).  Due to the many similar phenotypes between the two, 
it is believed that response to RSV and asthma inflammation may have common 
regulatory mechanisms (47, 48).  Furthermore, IL-9 mRNA is elevated in the lungs of 
infants with RSV bronchiolitis, and is believed to regulate MCM (46).  Analysis of the 
mouse genome found that MOLF/EiJ, PWD/PhJ and CAST/EiJ contain SNPs within the 
promoter region for Il9r.  Very little is known about Mpg, however its location within the 
QTL of chromosome 11 and significant p value may suggest that it is important to RSV 
response.   
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 The large number of QTLs identified in the genome scans that exceeded LogP 
values of 4 for the RSV disease phenotypes reconfirms that response to RSV is a 
complex (i.e. multigenic) trait.  However, the genome-wide significance of these QTLs is 
unknown, and while extremely promising and informative the significance of some of the 
identified QTLs is questionable.  Furthermore, it is likely that because of multiple gene-
environment (phenotype) and gene-gene interactions the haplotype association mapping 
approach was unable to identify all of the SNPs that modulate the observed responses, 
and important SNPs may be overlooked.  For example, data from previous studies 
suggest that IL-6 and IL-12 contribute to the RSV-induced inflammatory response in 
mice (39, 49-51).  Neither of these genes were found within the QTLs of this study, 
suggesting that these genes may not be polymorphic between strains; however expression 
of these genes is associated with St18 and Stat4 activation respectively (29, 52, 53), both 
of which were identified in this study.  Similar limitations are noted in other association 
mapping studies investigating complex phenotypes (25, 54).  While limitations to the 
approach are acknowledged, results from this method should be viewed as a starting point 
and follow-up mechanistic investigations of the identified candidate genes should provide 
substantial insight to RSV disease susceptibility.  It should be mentioned that haplotype 
association mapping was only performed on 4 of the 16 previously measured phenotypes.  
Pearson correlation coefficients indicated that the 4 phenotypes used for haplotype 
association mapping were the most relevant RSV phenotypes.  Haplotype association 
mapping for some of the less relevant phenotypes may also identify associations with 
genes important to RSV disease. 
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 Collectively this study details a clear genetic influence on RSV disease 
phenotypes using inbred strains of mice.  Six of the candidate genes in this study were 
found to have influence on the host response to RSV infection.  Previous knowledge 
along with data from this study suggest that Marco, Slc28a3, and Kif27 protect the host 
from RSV-induced inflammation; while St18, Stat4, Stat1, Mpg and Il9r contribute to the 
inflammatory response following infection.   
Using a similar approach a recent study linked several of the genes (e.g Stat4, 
Il9r) identified in the present study to RSV susceptibility (55).  In contrast to disease 
response phenotypes used in our investigation, Stark et al. used viral load as the RSV 
response phenotype and did not evaluate inflammatory or other immunological response 
phenotypes (6, 55).  While informative for mechanisms of infection, data presented 
earlier (Chapter 4) suggests that susceptibility to infection does not influence disease 
severity.  Therefore identifying genes that regulate susceptibility does not help elucidate 
the genetic mechanisms that regulate RSV disease severity.  In the current study 
identification of QTLs and candidate genes was based solely on disease phenotypes, 
suggesting that these genes are responsible for disease severity.   
Throughout the years many genes have been linked to RSV-induced pulmonary 
inflammation and injury, but the complexity of the disease phenotype makes it difficult to 
determine which genes are absolutely essential for response to RSV infection (9, 10, 56-
58).  The haplotype association analysis of clinically relevant RSV disease phenotypes 
across 35 inbred strains of mice identified a number of potentially important candidate 
susceptibility genes.  Association of nonsynonymous coding SNPs with RSV response 
phenotypes across the inbred strains suggests that further analyses of mechanistic roles of 
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the genes in RSV response should lead to novel insight about genetic susceptibility.  
Future investigations may evaluate the role of functional SNPs in homologous human 
genes. 
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Figure Legends 
 
Figure 5.1.  Genome-wide haplotype association mapping.  Manhattan plot of 
haplotype association mapping of RSV disease phenotypes, concentration of BAL total 
cells (A), PMNs (B), monocytes (C) and lymphocytes (D).  X-axis represents the 
genomic location.  Y-axis indicates the strength of the genotype-phenotype correlation.  
Each color block represents a different chromosome of the mouse genome.  
 
Figure 5.2.  Detailed view of representative significant QTLs associated with RSV 
disease phenotype and corresponding candidate genes.  Chromosome 10 association with 
total BAL cells 1 day post infection (pi) (A).  Chromosome 10 association with BAL 
PMNs 1 day pi (B). Chromosome 1 association with monocytes (C) and lymphocytes 1 
day pi (D).  
 
Figure 5.3.  Effect of candidate gene SNPs on BAL (total cell, monocyte, and 
lymphocyte) phenotypes among inbred strains of mice following RSV infection.  
Number above columns indicates the number of strains with the genotype.  Group means 
± SD are presented.  * Significantly different from wild-type genotype, p < 0.05. 
 
Figure 5.4.  Effect of Marco on pulmonary hypermeability.  Marco deficiency 
enhanced RSV-induced pulmonary hyperpermeability, determined by BAL protein 
concentration. Data presented as group mean ± SEM (n=3-5/group).  * Significantly 
different from genotype-matched vehicle control.  + Significantly different from 
infection-matched Marco+/+, p<0.05. 
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Figure 5.5.  Effect of Marco on pulmonary inflammation.  Marco deficiency enhanced 
RSV-induced pulmonary inflammation.  Numbers of PMNs, monocytes, lymphocytes, 
and macrophages were determined by BAL fluid analysis in Marco+/+ and Marco-/- mice 
following vehicle or RSV infection.  Data presented as group mean ± SEM (n=3-
5/group).  * Significantly different from genotype-matched vehicle control.  + 
Significantly different from infection-matched Marco+/+, p<0.05. 
 
Figure 5.6.  Pulmonary pathology following RSV infection in Marco+/+ and Marco-/- 
mice.  Arrows indicate areas of increased airway inflammation and bronchial epithelial 
proliferation (hyperplasia).  AV = Alveoli, BR = bronchus or bronchiole, BV = blood 
vessel.  Bar = 100mm.  
 
 130
 
 131
 
 132
 
 133
 
 134
 135
 
 136
Table 5.1.  QTLs associated with RSV disease severity identified by HAM.  Genes of 
interest were found within these QTLs, genes with a priori biological relevance to 
response to RSV infection are in bold.  Gene identifications are listed in Table 4.2.   
 
 
Phenotype QTL Genome position (Mb) Genes in region 
PMN (1 day pi) 1 Chr 10: 120.75-121.50 Gns, Rassf3, Tbk1, Xpot, 
Srgap, Tmem5 
1 Chr 1: 159.20-160.9 Astn1 
2 Chr 10: 5.91-6.76 Npbwr1, Rb1cc1, St18 
Total Cells (1 day pi) 
3 Chr 12: 114.00-117.26 Adam6, Ankrd12, Ptpn2 
1 Chr 1: 121.74-122.30 Tmem177, Sctr, Dbi, 
Steap3, Marco 
2 Chr 14: 70.41-71.51 Fndc3a 
Monocytes (5 day pi) 
3 Chr 15: 48.52-48.89 Csmd3 
1 Chr 1: 51.82-52.47 Myo1b, Stat4, Stat1, Gls, 
Nab1, Gm553 
2 Chr 4: 153.48-153.55 Prdm16, Actrt2, Mmel1, 
Tnfsf14, Hes5, Pank4, 
Plcl4 
3 Chr 11: 30.00-33.12 Spnb2, Acyp2, Psme4, 
Il9r, Cpeb4, Mpg, Mare, 
Tlx3, Rhbdtf1 
Lymphocytes (5 day pi) 
4 Chr 13: 57.91-58.57 Spock1, Klh13, Hnrpa0, 
Ubqln1, Gkap1, Kif27, 
Slc28a3, Hnrpk 
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Table 5.2.  Complete list of genes of interest identified through HAM.  Genes with a 
priori biological relevance based on the literature are in bold. 
 
Gene Symbol Offical Gene Name 
PMNs  
Chromosome 10 
Gns Glucosamine (N-acetyl)-6-sulfatase 
Rassf3 Ras association (RalGDS/AF-6) domain family member 3 
Tbk1 TANK-binding kinase 1 
Xpot Exportin, tRNA 
Srgap SLIT-ROBO Rho GTPase activating protein 
Tmem5 Transmembrane protein 5 
 
Total Cells 
Chromosome 1 
Astn1 Astrotactin 1 
                  chromosome 10 
Npbwr1 Neuropeptides B/W receptor 1 
Rb1cc1 RB1-inducible coiled-coil 1 
St18 Suppression of tumorigenicity 18 
chromosome 12 
Adam6 A disintegrin and metallopeptidase domain 6A 
Ankrd12 Ankyrin repeat domain 12 
Ptpn2 Protein tyrosine phosphatase, non-receptor type 2 
  
Monocytes 
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Chromosome 1 
Tmem177 Transmembrane protein 177 
Sctr Secretin receptor 
Dbi Diazepam binding inhibitor 
Steap3 STEAP family member 3 
Marco Macrophage receptor with collagenous structure 
Chromosome 14 
Fndc3a Fibronectin type III domain containing 3A 
Chromosome 15 
Csmd3 CUB and Sushi multiple domains 3 
 
Lymphocytes  
Chromosome 1 
Myo1b Myosin IB 
Stat4 Signal transducer and activator of transcription 4 
Stat1 Signal transducer and activator of transcription 1 
Gls Glutaminase 
Nab1 Ngfi-A binding protein 1 
Gm553 Predicted gene 553 
Chromosome 4 
Prdm16 PR domain containing 16 
Actrt2 Actin-related protein T2 
Mmel1 Membrane metallo-endopeptidase-like 1 
Tnfsf14 Tumor necrosis factor ligand superfamily member 14 
Hes5 Hairy and enhancer of split 5 
Pank4 Pantothenate kinase 4 
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Plcl4 Phospholipase C-like 4 
Chromosome 11 
Spnb2 Spectrin beta 2 
Acyp2 Acylphosphatase 2 
Psme4 Proteasome activator subunit 4 
Il9r Interleukin 9 receptor 
Cpeb4 Cytoplasmic polyadenylation element binding protein 4 
Mpg N-methylpurine-DNA glycosylase 
Mare Alpha globin regulatory element containing gene 
Tlx3 T-cell leukemia, homeobox 3 
Rhbdf1 Rhomboid family member 1  
Chromosome 13 
Spock1 Sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 
Klh13 Kelch-like protein 13 
Hnrpa0 Heterogeneous nuclear ribonucleoprotein A0 
Ubqln1 Ubiquilin 1 
Gkap1 G kinase anchoring protein 1 
Kif27 Kinesin family member 27 
Slc28a3 Solute carrier family 28 member 3 
Hnrpk Heterogeneous nuclear ribonucleoprotein K 
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Table 5.3.  Responses to RSV associated with SNPs in candidate genes identified by 
HAM.  Genes of interest containing SNPs with significant phenotypic associations were 
classified as candidate genes and are listed in bold.  
 
 
Gene Mutation 
Genomic 
Location 
(Mb) 
Geno-
type 
Amino 
Acid  
No. 
of 
Str
ains 
Phenotype, 
day pi 
Phenotype 
(mean ± 
SD) 
p-value 
Tbk1 121.000992 T Ser 28 PMNs, 1 day 187.9 ± 26 0.5072 
  C Gly 2  203.9 ± 
103 
 
        
St18 6.847409 C Thr 26 Total cells, 1 
day 
349.4 ± 40 <0.0001 
  G Ser 4  249.8 ± 29  
        
Marco 122.371364 A Thr 24 Monocytes, 5 
days 
332.8 ± 37 0.4692 
  T Ser 6  352.2 ± 
110 
 
 122.374458 A Asp 28 Monocytes, 5 
days 
315.1 ± 34 <0.0001 
  T Val 3  536.8 ± 
164 
 
        
Fndc3a 72.961494 T Thr 25 Monocytes, 5 
days 
342.3 ± 40 0.1035 
  C Ala 5  306.7 ± 55  
 72.974433 A Phe 26 Monocytes, 5 
days 
336.8 ± 39 0.9346 
  G Leu 4  334.9 ± 61  
        
Stat4 52.162526 C Thr 26 Lymphocytes, 5 
days 
35.4 ± 5.9 <0.0001 
  T Met 4  80.3 ± 37.8  
        
Spnb2 30.004580 A Ala 24 Lymphocytes, 5 
days 
39.8 ± 7.1 0.1760 
  T Ala 7  45.9 ± 21.3  
        
Kif27 58.389425 A Glu 26 Lymphocytes, 5 
days 
32.7 ± 5.5 <0.0001 
  G Gly 4  98.7 ± 36.7  
 58.445828 C Ala 28 Lymphocytes, 5 
days 
39.9 ± 7.0 0.0022 
  T Val 2  59.1 ± 19.0  
        
Slc28a3 58.657074 T Asn 26 Lymphocytes, 5 
days 
41.2 ± 6.8 0.9999 
  C Asp 4  41.4 ± 34.7  
 58.657166 T Lys 28 Lymphocytes, 5 43.6 ± 7.1 <0.0001 
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days 
  C Arg 2  6.6 ± 6.6  
        
Mpg 32.129868 C Ala 20 Lymphocytes, 5 
days 
38.2 ± 7.1 0.0239 
  G Gly 10  47.5 ± 14.3  
 32.127831 C Ser 21 Lymphocytes, 5 
days 
43.0 ± 8.2 0.0835 
  T Leu 9  36.6 ± 10.5  
 
 
CHAPTER 6 
 
GENE EXPRESSION PROFILES OF INBRED MOUSE STRAINS FOLLOWING 
RSV INFECTION 
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Introduction 
 Data from inbred strain screens indicate that susceptibility to RSV infection is a 
polygenic trait (1, 2).  Using a candidate gene approach and genome-wide haplotype 
association mapping, several genes linked to RSV susceptibility and immune response 
have been identified (3-6).   
Previous studies have identified statistically significant inter-strain variation in 
inflammation and lung pathology phenotypes among inbred mice (Chapter 5).  Moreover, 
haplotype association mapping has identified quantitative trait loci for a number of these 
RSV response phenotypes and candidate genes within them.  In the present study, a 
genomics approach was initiated to provide further insight to the mechanisms of 
differential susceptibility to RSV disease among inbred strains.  Global gene expression 
profiles were determined for lung homogenates obtained from RSV-susceptible 
BALB/cByJ and RSV-resistant C3H/HeJ mice.  In C3H/HeJ mice, gene expression was 
minimally altered by RSV infection.  However, gene expression did vary significantly as 
a result of RSV infection in responsive BALB/cByJ mice.  In the BALB/cByJ mice, a 
number of “biologically interesting” expression patterns were identified, but the most 
significant change in gene expression was noted 1 day following infection when a 
significant number of genes were either up-regulated or down-regulated.  Altered gene 
transcript expression approached baseline 5 days after RSV infection.   
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Material and Methods 
 
Microarray Data Analyses 
RNA was extracted from whole lung homogenates from each mouse within a given group 
and pooled (n = 3) to provide a single RNA sample for each experimental group.  Two 
arrays per group were hybridized.  Total RNA was used only after it passed quality 
testing performed using a 2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, 
CA).  Gene expression analysis was conducted using the Affymetrix Mouse Genome 430 
2.0 experimental platform. The log(10) of the Affymetrix processed signal intensity was 
visualized using Spotfire k-means clustering.  Visual inspection of clusters identified 9 
biologically interesting patterns.  Probes were collected for each pattern, and entered the 
probe lists (GenBank IDs from the chip) for each pattern into GeneSpringGX10 (Agilent 
Technologies, Inc., Santa Clara, CA) to analyze gene expression profiles.   
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Results and Discussion 
 Microarray analysis indicated that RSV infection significantly altered gene 
expression in both strains; however, changes in gene expression are greater in 
BALB/cByJ mice compared to C3H/HeJ mice (Figure 6.1).  One day following RSV 
infection over 850 genes were significantly upregulated or downregulated in both 
genotypes relative to vehicle controls; however, the observed gene expression was greater 
in BALB/cByJ mice than C3H/HeJ.  The Gene Ontology feature of GeneSpringGX10 
identified many of the differentially regulated genes; some of which have biological 
relevance and plausibility to RSV susceptibility and disease severity.  For example, initial 
analyses determined that expression of Mx1 (myxovirus 1), Mx2 (myxovirus 2), Oas1 
(2',5'-oligoadenylate synthetase 1), Oas2 (2',5'-oligoadenylate synthetase 2), Stat1 (signal 
transducer and activator of transcription 1) and Stat2 (signal transducer and activator of 
transcription 2) was significantly upregulated 1 day after RSV infection (Figure 6.2; 
clusters 6, 7, 10, 12, 13, 15).  Previous studies have found that Mx1 and Mx2 are 
responsible for specific antiviral activity against influenza virus infection (7).  A recent 
published study and preliminary data from this laboratory suggests that Mx1 and Oas1 
regulate susceptibility to RSV infection (1, 7, 8).   
 Relative to vehicle control BALB/cByJ mice, expression was significantly lower 
for approximately 100 gene transcripts in mice after RSV infection (Figure 6.2; clusters 
3, 5, 11).  Among these genes were Marco (macrophage receptor with collagenous 
structure), Xpot (exportin, tRNA), and Mpg (N-methylpurine-DNA glycosylase).  
Interestingly, previous studies associated these genes with pulmonary inflammation and 
injury (9-11), and haplotype association mapping analysis reported in Chapter 5 also 
linked QTLs that contained these genes to RSV-induced pulmonary inflammation.   
 Gene expression profiles found in clusters 11 and 14 (Figure 6.2) indicated that 
there are significant differences in gene expression between C3H/HeJ mice and 
BALB/cByJ mice at baseline.  This finding suggests that further investigation of this gene 
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set may identify genes or gene networks that predispose to differences in host 
susceptibility to RSV infection and disease.  Cluster 11 identifies genes for chemokines 
such as Ccl12 (Chemokine (C-C motif) ligand 12), and Cxcl3 (Chemokine (C-X-C motif) 
ligand 3) as well as Tlr4 (toll-like receptor 4).  Interestingly all of these genes are 
associated with inflammation (12-14).  Expression of these genes was greater in 
BALB/cByJ mice than in C3H/HeJ mice, which suggests these genes contribute to 
susceptibility to infection.  Cluster 14 identifies genes with greater expression in 
C3H/HeJ mice, these genes include Cyr61 (cysteine-rich, angiogenic inducer 61) and Fos 
(FBJ murine osteosarcoma viral oncogene homologue) both of which promote apoptosis 
(15-17).  Cluster 14 gene expression profiles along with phenotype data presented in 
chapter 5 suggest that these genes contribute to resistance to infection. 
 Initial microarray analysis of C3H/HeJ and BALB/cByJ mice has identified 
several interesting candidate genes, some of which are consistent with HAM analyses 
(Chapter 5).  Future microarray analysis on additional responsive and non-responsive 
strains will determine if the expression profiles identified in C3H/HeJ and BALB/cByJ 
mice are predictive of RSV disease severity in other strains of mice.  Programs such as 
IPA (Ingenuity Pathway Analysis) and DAVID (Database for Annotation, Visualization 
and Integrated Discovery) will be used to identify pathways responsible for RSV 
susceptibility and severity.  Subsequent studies using knock-out mice and cell lines will 
be used to confirm the role of these candidate genes in RSV disease.   
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Figure Legends 
 
Figure 6.1.  Effects of RSV on gene expression profiles.  Gene expression patterns for 
lung tissues from C3H/HeJ and BALB/cByJ mice infected with vehicle or RSV.  
Expression patterns of 854 genes were significantly affected by RSV (p<0.01).  (n=3 per 
group) 
 
Figure 6.2.  K-means cluster analysis of gene expression profiles.  Gene expression 
patterns for lung tissues from C3H/HeJ and BALB/cByJ mice infected with vehicle or 
RSV.  Expression patterns of 854 genes were significantly affected by RSV (p<0.01).  K-
means cluster analysis was performed on the Affymetrix genome array probes, and 16 
“biologically interesting” clusters were found among the 854 genes used in this analysis.  
(n=3 per group) 
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CHAPTER 7 
 
SUMMARY AND CONCLUSIONS 
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 The overall objective of this project was two-fold.  The first objective was to 
utilize a multi-disciplinary approach to investigate the role of a candidate susceptibility 
gene (Cx3cr1) in response to O3 and, subsequently, to RSV.  The second objective was to 
utilize a positional cloning approach to identify genes that contribute to RSV disease 
phenotypes.  It was hypothesized that these studies would identify mechanisms related to 
oxidative stress and inflammation that may be common to ozone and RSV disease. 
Previous studies have characterized the role of Cx3cr1 in pulmonary 
inflammation following chronic exposure in humans.  Pulmonary inflammation and 
injury were greatly diminished in individuals with CX3CR1 polymorphisms following 
chronic exposure to coal dust compared to individual with wild-type CX3CR1 (1).  
Results of the present study demonstrated that sub-acute O3 exposure (0.3 ppm) induced 
pulmonary inflammation, and Cx3cr1 contributes significantly to the inflammatory 
response.  That is, when compared to wild type mice, targeted deletion of Cx3cr1 
significantly reduced the inflammatory response to O3 exposure, thus implicating Cx3cr1 
as an important determinant of host response to this environmental oxidant.  To further 
investigate the mechanism through which Cx3cr1 regulates O3-induced pulmonary 
inflammation, the role of IL-17 was examined in relation to Cx3cr1 activity.  Targeted 
deletion of the IL-17 receptor (Il17ra) significantly reduced the inflammatory response 
induced by O3 exposure thus suggesting that, like Cx3cr1, Il17ra contributes to the O3 
effects.  Moreover, Il17ra expression correlated with Cx3cr1 expression, suggesting that 
these receptors work together to modulate pulmonary inflammation and injury.  Data 
from this dissertation and earlier studies suggest that Cx3cr1 may contribute to oxidative 
stress response following exposure to inhaled pollutants.   
Oxidant stress has been found to be a contributing factor to the pathogenesis of 
RSV-induced lung injury (2).  Further, fractalkine (Cx3cl1), the main endogenous ligand 
for CX3CR1, is a chemoattractant for T cells and monocytes and also promotes strong 
adhesion of leukocytes to activated endothelial cells where it is primarily produced and 
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expressed (3, 4).  Recent studies have also found that the G protein of respiratory 
syncytial virus is able to bind to Cx3cr1 (5).  These observations led to the hypothesis 
that Cx3cr1 is an important component of the inflammatory response induced by viral 
infection.  To test this hypothesis, Cx3cr1+/- and Cx3cr1-/- mice were infected with RSV 
and BAL was analyzed for inflammatory cell infiltration and total protein.  Results 
indicated that lack of Cx3cr1 reduced pulmonary inflammation and injury following RSV 
infection.  Other in vivo and in vitro studies are consistent with these observations (5-7).   
 
Two approaches can be used to identify genes that regulate susceptibility (8-10).  
The first and most common method is the candidate gene approach, in which genes are 
chosen a priori as likely mechanisms that influence the phenotype of interest.  
Association is assessed between the phenotype of interest and polymorphisms within the 
candidate gene(s).  In this dissertation the candidate gene approach was used to 
demonstrate that Cx3cr1 and Marco are important modulators of RSV susceptibility and 
inflammation.  This approach is effective for identifying genes that regulate the 
phenotype of interest.  However, since it does not examine the entire genome it is unable 
to identify all the genes that affect the phenotype.  Furthermore this approach fails to take 
gene-gene interaction into account (11).  The second approach to identification of 
susceptibility genes is to perform a genome scan (positional cloning).  Similar to the 
candidate gene approach this method associates gene expression and polymorphisms with 
the phenotype of interest.  However, unlike the candidate gene approach a genome-wide 
screen is used to identify linkage to any chromosomal interval throughout the entire 
genome between two or more differentially responsive strains.  This approach requires no 
prior knowledge of gene function and has the potential to discover novel disease genes.  
The second part of this dissertation was dedicated to identifying the genes responsible for 
susceptibility to RSV infection as well as the genes that regulate the response to 
infection. 
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An important characteristic of the inbred mouse is the availability of the complete 
genome sequence, and the many similarities between the human and mouse genomes 
(12).  The continuous strain distribution patterns found for all the phenotypes measured in 
this study demonstrate that similar to humans, RSV infections elicits a wide range of 
disease severity that can be measured and is highly heritable. 
Previous studies have shown that susceptibility and response to RSV infection is a 
multigenic trait, but only a few genes including Cx3cr1 have previously been associated 
with RSV disease (13-15).  RSV viral titer is often used as a marker of susceptibility to 
RSV infection; using only this phenotype previous studies found that susceptibility is 
multigenic, and AKR/J are the most susceptible to infection, and C57BL/6J are the most 
resistant to infection.  These findings are consistent with viral load data reported in this 
dissertation.  However, these findings are inconsistent with data for RSV disease 
phenotypes (BAL measurements, changes in body weight, histopathology), and Pearson 
ranked correlation coefficients indicate that RSV disease severity is not influenced by 
viral load in the lung. 
In the present study, haplotype association mapping (HAM) was used to identify 
QTLs and candidate genes that determine susceptibility to inflammatory and other 
pulmonary responses to RSV infection.  A similar approach has been used by other 
investigators to identify genetic mechanisms responsible for susceptibility to RSV 
infection (14).  While determining the genes that regulate susceptibility to infection is 
informative, it does not explain the differential disease responses found between inbred 
mouse strains.  Furthermore, current literature and data presented in this dissertation 
(Chapter 4) suggest that the signs and symptoms of RSV disease are directly related to 
the host’s response to infection, and not the viral concentration (16).  Deciphering the 
mechanisms responsible for this differential response is important in order to understand 
why certain individuals only present cold-like symptoms after RSV infection, while other 
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individuals require hospitalization.  Using haplotype association mapping St18, Marco, 
Stat4, Kif27 and Slc28a3 were identified as candidate genes for regulating inflammation 
and injury in response to RSV infection.  All of the identified candidate genes are known 
regulators of inflammation (especially bronchiolitis) and cell cycle (17-21).   
Polymorphisms within these genes were significantly associated with RSV-
induced pulmonary inflammation.  Polymorphisms of Kif27 result in cilia dysfunction, 
which is associated with bronchiolitis and MCM (21, 22).  Interestingly, inbred strains 
such as CAST/EiJ and KK/HlJ which have a nonsynonomous coding SNP (Glu1335Gly) 
in Kif27 were among those inbred strains with the greatest amount of intraepithelial 
mucus concentration 5 days following RSV infection.  These results suggest that Kif27 
may have a role in determining response to RSV and warrant additional investigation to 
the potential mechanism(s) through which this gene influences host susceptibility. 
Little is known about the function of Slc28a3 other than it is a membrane 
transport protein.  Data from this study suggests that Slc28a3 contributed to pulmonary 
inflammation and polymorphisms of this gene significantly attenuated the response.  St18 
is a transcription factor that regulates expression of proinflammatory genes such as IL-6, 
IL-1α, and TNF-α in human fibroblast (18).  Statistical analysis suggests that 
polymorphisms of this gene results in a decreased inflammatory response.  Stat4 is also 
an inflammatory mediator and operates downstream of IL-12 (23).   Specifically, studies 
have shown that Stat4 contributes to pulmonary inflammation (19, 24-26) and Stat4 
deficiency is associated with protection against ischemic injury (27).  However, in this 
study polymorphisms of this gene elevated inflammation in the lung.  However, no Stat4 
coding SNPs were found in C3H/HeJ mice and other inbred strains with minimum lung 
injury following RSV infection.  The role of Stat4 in the immune response following 
RSV infection cannot be determined based on these data, investigation into activation and 
expression of IL-12 may provide insight into the role Stat4 plays in response to RSV.     
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The role of Marco in relation to RSV disease in mice was further investigated.  
Targeted deletion of Marco significantly enhanced RSV-induced injury and 
inflammation, especially the lymphocyte response.  These findings were consistent with 
the HAM analysis which identified a QTL on chromosome 1 that encompassed Marco.  
Interestingly, similar to RSV, Marco also was found to have an important role in the 
inflammatory response to O3 (28), suggesting another potential common response 
mechanism for these two environmental agents.  Similar “proof of concept” 
investigations of other candidate genes identified in the present study should provide 
unique, important insight to roles of these genes in susceptibility to RSV disease.   
HAM identified Il9r as a gene of interest.  Il9r regulates inflammation and lung 
hyper-reactivity associated with allergic asthma, both of which are prominent human 
RSV phenotypes.  Recent studies have also linked Il9r expression to MCM and 
bronchiolitis.  SNP analysis found that MOLF/EiJ, PWD/PhJ, CAST/EiJ mice have Il9r 
coding SNPs; and these same inbred strains presented the minimum amounts of MCM 
following RSV infection.  The association of these SNPs with reduced MCM suggests 
that Il9r may regulate RSV-induced bronchiolitis, which is associated with severe RSV 
infection. 
Genome sequence analysis revealed that wild-derived inbred strains (CAST/EiJ, 
PWD/PhJ, MOLF/EiJ, WSB/ EiJ) contain coding SNPs of Myd88, Tlr4, Mx1, Mx2 and 
Il9r, which may explain why these strains were relatively nonresponsive to RSV 
infection. 
 This HAM approach provides an important platform for indentifying gene(s) that 
are responsible for specific, well-characterized phenotypes with high heritability.  
Microarray analyses were performed to identify gene expression patterns that change 
throughout the course of disease and may be predictive of RSV disease phenotypes.  
microarray analyses identified numerous genes with greater expression following RSV 
infection compared to vehicle controls.  Most of the genes with enhanced expression after 
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infection were associated with inflammation, specifically chemokines such as fractalkine; 
the ligand for Cx3cr1.  This was not surprising since a number of the RSV disease 
phenotypes (e.g. pulmonary edema, emphysema, pulmonary epithelial damage) are 
linked to inflammation.  Expression of inflammatory mediators 1 day after infection was 
consistent with BAL and pathology data of this study (i.e. the greatest changes in gene 
expression were found 1 day after infection).  Changes in gene expression profiles of the 
RSV-non responsive C3H/HeJ inbred mouse were markedly reduced compared to 
expression profiles of the RSV-responsive BALB/cByJ strain.  Using microarray analysis 
(genomics) together with HAM (genetics) is a powerful approach to identify genetic 
polymorphisms and expression, as well as their interaction (genetical genomics) to 
provide insight into the genetic mechanisms of RSV disease.   
While preliminary, initial integration of the candidate genes and gene networks 
identified in this study via HAM and microarray analysis have identified potentially 
interesting targets for future investigation.  For example, initial query of the array data via 
cluster analyses found genes that regulate virus attachment and replication such as Mx1 
and Mx2 are highly expressed in responsive strains compared to low responsive strains.  
A recent study by Stark et al. (13) found similar results using F2 mice; furthermore, 
unpublished in vitro data from this laboratory suggest that functional polymorphisms of 
Mx1 significantly decrease susceptibility to RSV infection (Ciencewicki, pers. comm.).  
Another example of a potentially important gene identified by these analyses is Myd88, a 
critical signaling molecule in Tlr4-mediated innate immunity.  Myd88 is of particular 
interest because both HAM and microarray suggested Myd88 was associated with RSV 
disease susceptibility and response.  Past studies found that Myd88 was essential to 
inflammation in RSV disease (29, 30), and suggests further validation of Myd88 as a 
candidate gene for further validation in the model used in this study.  
Tlr4 is another gene of great interest in this model.  A number of studies have 
suggested that Tlr4 is necessary for RSV disease and polymorphisms of Tlr4 are linked to 
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mild RSV disease in animal models and humans (29, 31).  In the present study, 
microarray analysis determined that Tlr4 was differentially expressed between C3H/HeJ 
and BALB/cByJ mice following vehicle, suggesting that Tlr4 may regulate susceptibility 
to RSV infection.  Furthermore, RSV disease phenotypes were significantly greater in 
C3H/HeOuJ (Tlr4 normal) compared to C3H/HeJ (Tlr4 mutant) mice (see Chapter 4), 
which indicates that Trl4 may not only regulate susceptibility to RSV infection, but it 
may contribute to disease severity as well.  These results are therefore consistent with a 
role for this gene in RSV disease, and further investigation into the mechanism(s) through 
which Tlr4 modulates disease could provide insight to intervention strategies to reduce 
disease severity.  For example, other disease/ injury models indicate that Tlr4 activates 
Myd88 to induced pulmonary injury and inflammation.  Additional in vitro and in vivo 
studies could determine if Tlr4 uses this same mechanism to regulate RSV disease.  
Supporting earlier findings in this dissertation, microarray analysis found Cx3cr1 
was differentially expressed between high and low responders.  Cx3cr1 along with other 
genes coding for chemokines (e.g. Ccl12, Cxcl1) were significantly upregulated 
following RSV infection relative to vehicle controls.  However, RSV infection resulted in 
a significantly greater increased gene expression in high responders (BALB/cByJ mice) 
relative to low responders (C3H/HeJ mice).  No significant difference in Cx3cr1 
expression was found between high and low responders in vehicle control groups, 
indicating that Cx3cr1 contributes to RSV disease severity, but may not influence disease 
susceptibility.  
As expected microarray analysis found that numerous genes were upregulated 
following RSV infection; however, it was determined that several genes were 
significantly downregulated in high responders following RSV infection.  These include 
genes coding for Arrdc3 (arrestin domain containing 3) and Cyr61 (cysteine rich protein 
61).  However the same genes were upregulated in non-responsive strains 1 day after 
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infection, suggesting that these genes impede RSV-induced inflammation and injury and 
provide protection against RSV infection.  
It is important to note that the murine model of RSV disease has some limitations.  
Probably the greatest criticism is that pathogenesis of RSV disease in mice fails to mimic 
what is observed in humans.  Specifically RSV infection does not result in a measurable 
degree of morbidity, eosinophilia, nor acute respiratory distress syndrome, and RSV viral 
loads in mice are typically low (32, 33).  For these reasons some investigators suggest 
that pneumonia virus of mice (PVM) is a more accurate model of human RSV infection 
(15).  Unlike RSV, PVM infection results in a broader range of phenotypes including 
death.  In this study, infection with 1x106 pfu of RSV-19 resulted in wide range of 
disease phenotypes, but no deaths resulted from infection.  Other investigators have 
attempted to use higher doses of RSV-19 in order to mimic human disease; however, this 
resulted in mass mortality within 2 days, and 1x106 pfu of RSV-19 is believed to be the 
dose that most accurately reflects human RSV disease.   
While some criticisms of this model are valid, they largely stem from the fact that 
most previous investigations of this model use a single inbred strain of mouse.  The 
approach used in the present studies characterized important human disease phenotypes 
across many inbred strains and identified strains of mice with a wide spectrum of RSV 
disease that approximates the human experience.  This multiple strain approach leveraged 
with the extensive genetic information available for multiple strains to perform HAM can 
provide gene candidates for testing in human populations. 
 In summary the inbred strain screen identified high and low responders to RSV 
infection.  HAM analysis of these strains identified several genes that were linked to 
disease progression, inflammation and injury following RSV infection.  Microarray 
analysis also indicated that many genes were differentially expressed between high and 
low responder strains prior to and after RSV infection.  Identification and validation of 
the genes and gene patterns will provide insight into what causes differential disease 
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severity in individuals.  It is also possible that the gene expression profiles can be used to 
predict disease severity in additional mouse strains.  These gene profiles may be used to 
predict disease severity in humans.  If informative, they could significantly advance 
current novel therapies for RSV infection.  At the present time treatment options for RSV 
are still limited.  Palivizumab and RSV immune globulin intravenous (RSV-IGIV) have 
been approved for prophylactic use (34).  Effective treatment requires multiple doses of 
either drug, which can be very costly, and not very cost efficient considering most 
individuals only experience a mild form of the disease (35).  By indentifying the genes 
that regulate RSV infection and thus the individuals prone to severe cases of RSV, 
current treatments can be targeted specifically to these individuals, 
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